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Abstract
Kiwifruit consumption is well known to have a positive impact on digestive health. Actinidin
and kiwellin, two kiwifruit proteins have been characterised because of their importance in
Actazin™ that is produced from kiwifruit to aid digestion. A biophysical characterisation was
carried out for both proteins and the catalytic activity of actinidin was measured during the
production of Actazin™ to assess if kiwifruit processing was detrimental to the catalytic rate.
Actinidin, purified from A. deliciosa cultivar showed that a decrease in enzymatic activity
could be from partially inactivated actinidin. Similarly actinidin from Actazin™ became
inactivated when the powder was solubilised in buffer. Most of the lost activity could be
recovered when a reductant was added and it is hypothesised that the catalytically important
cysteine residue was becoming oxidised by a chemical species that was present in the
solubilised kiwifruit powder.
Freezing, thawing, and storing the processed kiwifruit pulp resulted in the largest drop of
total actinidin activity of 46%. Freeze drying the frozen pulp surprisingly did not significantly
affect the retention of actinidin despite incurring prolonged heat stress. Further studies that
assess the effects that freezing and thawing have on the stability of actinidin is therefore
suggested.
Kiwellin was characterised using a number of analytical techniques and was shown to be a
monomeric protein in solution that had a high melting point. It was suggested that disulfide
bonds and salt bridges could be stabilising kiwellin, which was also highly dynamic in
solution. Kiwellin did not show the presence of any secondary structures, which is in contrast
to previous studies and small angle X-ray scattering revealed that kiwellin had an elongated
shape. The dynamic nature of the protein may have implications for the interactions between
kiwellin and actinidin, which has been previously shown and this could be related to the
physiological function of kiwellin.
viii
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Chapter One : Introduction
1.1 Overview
Since the introduction of kiwifruit vines to New Zealand in the 1900's the industry has grown
and is now a major contributor to the economy. Improved growing practices and a unified
global marketing campaign from Zespri International Ltd has allowed New Zealand growers
to produce large quantities of fruit each season and export this to a global market. A
significant portion of the fruit produced is classified as 'process grade' and can be used to
develop kiwifruit products, such as those in the health food industry. The growing awareness
of consumers to the nutritional value of foods has increased the demand for naturally derived
food products that have a beneficial impact on health. Kiwifruit consumption has been shown
to have positive impacts on health and can relieve symptoms of disease states, such as those
involving the digestive system. Fibre, bulking, and bioactive proteins, that are unique to
kiwifruit are attributed to the improvements seen in digestive health.
This Master's thesis is a collaborative research project with the biotechnology company
Anagenix Ltd which produces the kiwifruit product, Actazin™, which is sold as a digestive
aid. The aim of this thesis is to understand how various factors during the production of
Actazin™ affect the activity and stability of the bioactive protein, actinidin. Additionally we
aim to further characterise actinidin and kiwellin, another kiwifruit protein.
1.2 Introduction to the kiwifruit industry in New Zealand
1.2.1 Kiwifruit production in New Zealand
Kiwifruit or Chinese gooseberry, is the fruit from a woody vine that is native to China. Seeds
were first introduced into New Zealand in 1904 and these plants were used to develop
cultivars that were grown in commercial orchards, which became established in the 1930's
(Ferguson, 2004). Production in New Zealand has increased substantially since the first
orchards were established. In 2012 New Zealand produced 376,400 tonnes of kiwifruit,
which, when compared to other countries rated highly (Figure 1). In recent years, the
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production has, however, declined and this has been the result of the widespread prevalence
of the kiwifruit pathogen, Pseudomonas syringae pv. actinidiae (Psa) (Kiwifruit-Vine-Health,
2014). New cultivars that are resistant to Psa are expected to return the production to pre-Psa
levels and will be important for the recovery of the kiwifruit industry (MPI, 2014). Europe
and Asia are major export markets for kiwifruit produced in New Zealand (Zespri, 2013-
2014) and the fruit is largely sold as fresh fruit during the kiwifruit off-season in the Northern
Hemisphere.
Figure 1: Global kiwifruit production in 2012 (FAOSTAT, 2012).
1.2.2 Actinidia genus
Kiwifruit belong to the genus Actinidia. There are 55 species recognised in this genus and
several species are commercial grown, such as A. deliciosa, A, chinensis, A. arguta, A.
eriantha, A. kolomikta, and A. polygama (Datson et al., 2011). A. deliciosa cv. Hayward is the
most widely grown cultivar and is often referred to as green kiwifruit. A. chinensis cultivars
are also widely distributed and new cultivars like Zespri® Hort16a and SunGold (gold
kiwifruit) are increasingly popular due to the desirable flavour and textural properties that
these cultivars have. Overall green kiwifruit accounts for approximately 85% of commercial
kiwifruit grown in New Zealand, while gold kiwifruit accounts for the remaining 15%
(Datson et al., 2011). The diversity of species in the Actinidia genus has contributed to a
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strong selective breeding program, which continually introduces new varieties that have
desirable characteristics. One example of this is the introduction of Zespri® SunGold, which
has an increased resistance to Psa when compared to other cultivars. This has had important
economic implications for the kiwifruit industry in New Zealand after the pathogen
devastated the Zespri® Hort16a crops (Zespri, 2013-2014).
1.2.3 Growing kiwifruit as a horticulture crop
Kiwifruit vines favour warm, moist and sheltered growing conditions, not unlike those
experienced in regions of China that have a high presence of kiwifruit vines. The distribution
of kiwifruit orchards in New Zealand reflect these growing conditions. The Bay of Plenty in
the North Island of New Zealand is responsible for producing 77% of the total kiwifruit in the
country (NZ-Statistics, 2007) and these growing conditions combined with improved
growing practices which have resulted in substantial yields of kiwifruit. Kiwifruit yields per
hectare in New Zealand are the highest in the world. This has resulted in a large national
production of kiwifruit which is sold as fresh fruit or a processed product.
Figure 2: Global yields for kiwifruit harvests in units of hectograms per hectare (Hg/Ha) (FAOSTAT, 2012).
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1.2.4 Economic importance to New Zealand
The kiwifruit export market contributes greatly to the New Zealand economy and this has
been, in part, created by a global reputation of producing a high quality product. While Psa
has been attributed to a recent loss in revenue, the export market of fresh fruit was still worth
$817 million in the year ending March 2014 after 89 million trays were exported (MPI,
2014). As the industry recovers from Psa the economic returns are forecast to increase to over
$1 billion by 2018. The marketing conducted by Zespri International Limited helps to
increase the value of kiwifruit and this has consequently allowed New Zealand to be the
world's largest seller of kiwifruit (Zespri, 2013-2014), despite only producing around a third
of the world's total kiwifruit production (Figure 1). Advertising the nutritional content of
kiwifruit is a key focus of the market campaigns used by companies in the kiwifruit industry
and this has also promoted more scientific research to be conducted to understand the
relationship between kiwifruit consumption and a healthy lifestyle.
1.3 Processed kiwifruit products
1.3.1 Actazin™ production
Up to one fifth of the harvested fruit is classified as 'process grade' and is not exported as a
whole fruit (Warrington et al., 1990). The process grade kiwifruit can be transformed into
kiwifruit products that are sold in the health-food, beverage, and cosmetic industries.
Actazin™ is a kiwifruit product that is produced by Anagenix Ltd from processed kiwifruit
and utilises the bioactive components that are naturally present in kiwifruit to aid digestion.
The production of Actazin™ involves pulping kiwifruit that is then freeze dried to produce a
kiwifruit powder. The process is summarised in Figure 3 and several stages have been
identified to be important for the production of Actazin™. These include: fruit harvesting,
post-harvest ripening and storage, pulping, and freeze drying.
Fruit harvest
Kiwifruit used to produce Actazin™ is harvested between March and May in the Bay of
Plenty. Commercial harvesting begins after the fruit has reached a certain stage of maturity.
This stage is correlated with changes in the composition of the fruit, which makes the fruit
desirable for consumption. Soluble solids concentration, flesh firmness, and sugar
composition have all been measured as parameters that reflect the maturity of the fruit
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(Bonvehi et al., 1997) and are commonly measured to determine when the commercial
harvest will commence.
Post-harvest ripening and storage
Harvested fruit is transported to a local pack house where the 'process grade' is separated
from 'export grade' and 'reject grade' fruit. The fruit is then stored under cool storage before it
is ready to be processed into a pulp. Fruit stored at a temperature of 0oC ± 0.5oC with a
relative humidity of at least 95% with no ethylene in the air has been found to be optimal for
storing kiwifruit between 4-6 months (Warrington et al., 1990). The fruit is ripened at
ambient temperature (~12-15oC) before it is pulped at the Kiwifruit Processing Company Ltd,
which is also located in the Bay of Plenty. A qualitative firmness and sensory test of the
ripened fruit confirms that the fruit is at a sufficient ripeness to be pulped. The fruit is also
graded throughout the ripening to remove any fruit that is over ripe or spoiled as the result of
microbial contamination.
Pulping
The pulping is an automated process that removes the skin, seeds, and central core from the
kiwifruit. Part of the pulping process involves pressing of the kiwifruit skin so that any
residual pulp is removed off the skin. The process from whole kiwifruit to a pulp takes
approximately 3-5 minutes and is conducted under temperature control. Periodically the
batches of pulp are tested to assess qualities, such as viscosity, sugar composition, and pH
before the batches are blast frozen and stored at -20oC.
Freeze drying
Freeze drying is conducted at Genesis Bio-Laboratory Ltd in Christchurch. Frozen blocks of
the kiwifruit pulp are transported from the Bay of Plenty, under refrigeration upon the
demand for Actazin™. The blocks are cut into ~1 cm thick slices and placed onto trays before
being stored at -20oC until the freeze drying commences. Freeze drying involves drying the
frozen product by increasing the temperature inside a sealed freeze dryer that has low
pressure. This removes the moisture without damaging the structural integrity of the product
over a period between 24-48 hours. After the pulp has been sufficiently dried the resulting
block of powder is milled to a powder in the presence of anti-caking agents before the
powder is packaged for exporting.
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Figure 3: Process flow diagram of Actazin™ production.
1.4 Health benefits from kiwifruit consumption
1.4.1 Nutrients important for health
Regular consumption of fresh fruit and vegetables are well known to provide personal health
benefits. Many of the health benefits are attributed to the presence of bioactive compounds in
these natural products. For example antioxidant compounds, such as vitamin C have shown
that they can have a protective effect for a variety of disease states, including several types of
cancer (Steinmetz et al., 1996) and also functional bowel disorders, which often incurs high
oxidative stress (Russo et al., 2012). A wide selection of plant proteins have also been shown
to have bioactive properties and exhibits a wide diversity of implied health benefits such as
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showing immunomodularoty, anti-hypertensive, anti-carcinogenic, anti-microbial and anti-
inflammatory properties (Kitts et al., 2003).
Kiwifruit is a rich source of nutrients, including bioactive compounds. In particular kiwifruit
is a good source of several nutrients, such as dietary fibre, potassium, vitamin C, vitamin E,
and folate. These nutrients heavily contribute to kiwifruit being regarded as 'nutrient dense'
and a comparison with other common fruits shows that kiwifruit rates highly among them
(Table 1). Other bioactive compounds that are found in kiwifruit include: polyphenols (Du et
al., 2009), flavonoids (Fiorentino et al., 2009), and bioactive proteins (Maddumage et al.,
2013). Although the level of these compounds is not exceptionally higher than other fruits
(USDA, 2011) they still provide important health benefits. For example the array of
phytochemicals in A. deliciosa have shown high antioxidant and radical scavenging
capabilites (Fiorentino et al., 2009), and the bioactive protein, actinidin, that is unique to
kiwifruit, is an important contributor to the digestive health benefits that kiwifruit have
shown to provide (Chang et al., 2010).
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Table 1: Amount of selected nutrients (folate, vitamin E, vitamin C, potassium, dietary fibre) measured in
















Apples, raw, fuji, with
skin
3 0.2 -- 109 2.1
Bananas, raw 20 0.1 8.7 358 2.6
Blueberries, raw 6 0.6 9.7 77 2.4
Grapes, muscadine, raw 2 0.2 6.5 203 3.9
Kiwifruit, gold, raw 34 1.5 105.4 316 2.1
Kiwifruit, green, raw 25 1.5 92.7 312 3.0
Oranges, raw, 30 0.2 53.2 181 2.4
Pears, raw 7 0.1 4.3 116 3.1
Pineapple, raw, all
varieties
18 0.0 47.8 109 1.4
Strawberries, raw 24 0.3 58.8 153 2
1.4.2 An overview of health benefits from kiwifruit consumption
A wide range of health benefits have been attributed to kiwifruit consumption and this has
had a major impact on marketing kiwifruit in increasingly health conscious societies. The
strength of the health claims differs and this is correlated with the type and amount of
research that has been conducted. Kiwifruit extracts have shown anti-microbial (Eshamah et
al., 2014), anti-cancer (Motohashi et al., 2002), and anti-inflammatory (Edmunds et al.,
2011) properties using in vitro assays. This, however has been shown to not always be
reliable when the assay is extrapolated to an in vivo system (Edmunds et al., 2012). A number
of clinical trials have been conducted which measured the effects that regular kiwifruit
consumption have on disease-states, and this has provided more applicable data to the
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benefits of kiwifruits on personal health. For example the anti-oxidant capacity (Ko et al.,
2005), risk of cardiovascular disease (Karlsen et al., 2013), and DNA repair capacity (Brevik
et al., 2011) of patients all responded favorably during the trials. Digestive health can also be
improved and there has been substantial evidence that consuming kiwifruit can relieve
constipation in a number of populations (Chan et al., 2007; Chang et al., 2010; Rush et al.,
2002).
1.4.3 Improved digestive health
Digestive health problems
Functional bowel diseases are wide spread and can have severe implications on quality of
life. Irritable bowel syndrome (IBS), one of the most common gastrointestinal disorders
shows high prevalence in developed countrities and in 1998 there was upwards of 15 million
cases in the United States, which directly and indirectly cost more than $1.5 billion to treat
(Sandler et al., 2002).  According to the Rome III criteria IBS is diagnosed by symptoms,
such as recurrent abdominal pain or discomfort and changes in stool form and frequency
(Drossman, 2006). However a lack of a definitive diagnosis for IBS patients has prompted the
use of a number of different treatment options, including pharmacologic treatments and
increasing the  uptake of dietary substances that have been shown to reduce the symptoms of
IBS (Yoon et al., 2011). The complexity of the disease and associated risk factors encourages
further research and treatments for the symptoms that this disease can be responsible for.
Effects of kiwifruit on digestive flow
Improving digestive health in patients who suffer from constipation is desirable and kiwifruit
consumption supports this goal. With a group of 33 patients who suffered from constipation
Chan, et al (Chan et al., 2007) demonstrated that ingesting kiwifruit twice daily for 4 weeks
significantly improved the transit time and satisfaction of excretion when compared to a
control group. Another clinical trial that measured the frequency of defecation in elderly on a
similar kiwifruit diet also measured an increase and it was proposed that kiwifruit had a
laxative effect in elderly populations (Rush et al., 2002). A third study observed the effects
that kiwifruit had on 41 patients who suffered from IBS and had symptoms of constipation.
The findings suggested that kiwifruit consumed daily, for 4 weeks shortens colon transit time,
increases defecation frequency, and improves bowel function in adults who have been
diagnosed with IBS (Chang et al., 2010). All of the above studies used kiwifruit from the
10
Actinidia deliciosa Hayward cultivar and clearly showed that in-comparison to a control
group regular consumption of kiwifruit had a positive effect on digestive health.
Mechanism of action
Several components of kiwifruit are attributed to the mechanisms that increase defecation and
which thereby relieves patients that are suffering from constipation. Diets high in dietary
fibre are well known for promoting digestive health (Buttriss et al., 2008) and research has
shown that the fibre in kiwifruit shares these properties. Kiwifruit, similar to other fruits, is a
good source of dietary fibre (Table 1). An intake of 100 g of green kiwifruit will provide
around 10% of the recommended daily intake of fibre (Ministry-of-Health, 2003). Using an
in vitro assay the properties of kiwifruit fibre (both soluble and insoluble) were investigated
and was shown to have a strong water retention and swelling capacities, which will have
positive implications for digesta transiting through the gastrointestinal tract (Mishra et al.,
2012). The bioactive protein, actinidin is also an important contributor to improved digestive
health (Montoya et al., 2014). Actinidin is a cysteine protease and catalytically functions by
cleaving proteins (Rawlings et al., 2012). Kiwifruit extracts containing actinidin have
enhanced the digestion of proteins, particularly those from milk, meat, and cereals in a small
intestine and gastric digestion in vitro model (Kaur et al., 2010a, 2010b). Similarly actinidin
from Actinidia deliciosia cv. Hayward in a freeze dried powder increased the gastric protein
digestion in growing rats (Montoya et al., 2014). The gastric emptying rate for some of the
dietary proteins assessed also increased by up to 43% and this is likely to be a mechanism for
kiwifruit increasing defecation that has previously been observed (Rush et al., 2002). Kissper,
another bioactive protein and the cleavage product of the precursor protein, kiwellin is also
postulated to increase digestion by its pore-forming voltage gated activity observed in an
intestinal cell in vitro model (Ciardiello et al., 2008), however further investigation of this
bioactive function is needed for confirmation.
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2 Chapter Two : Actinidin Purification
and Characterisation
2.1 Actinidin isoforms in kiwifruit
Actinidin is classified as a cysteine protease and cleaves peptide chains by enzymatic
cleavage. The physiological function of actindin is largely unknown, however it may have a
regulatory role of processing of other proteins, including kiwellin (Tuppo et al., 2008) and a
class 4 chitinase (Nieuwenhuizen et al., 2012). The protease has also shown anti-bacterial
activity (Eshamah et al., 2014) and has limited the development of larvae for the leafworm,
Spodoptera litura. This could imply that actinidin has a role in plant defence. These functions
are similar to those proposed for other cysteine protease (Konno et al., 2004; van der Hoorn,
2008).
Actinidin exists as multiple isoforms in kiwifruit. In A. deliciosa, 2 isoforms and 6 other
cysteine proteases were identified (Nieuwenhuizen et al., 2007) after a cDNA sequence of
actinidin (Podivinsky et al., 1989) was BLAST searched against a kiwifruit EST database
(Crowhurst et al., 2008). A phylogenetic comparison of plant cysteine proteases showed that
despite conservation of several catalytically and structural important residues (Figure 4), the
isoforms grouped into different clades (Nieuwenhuizen et al., 2007). The KFAct clade had
both the ACT1A isoform and the ACT2A isoform. The six other kiwifruit cysteine proteases
(KFCp1-6) were grouped in a variety of clades that also contained cysteine proteases from
other plant species. The isoforms and other cysteine proteases are expressed as preproproteins
and contains a signal peptide and extension sequences at the N- and/ or C-terminals regions
(Nieuwenhuizen et al., 2007). It is hypothesised that actinidin is expressed as a zymogen and
requires post-translational processing of these extension sequences before becoming active in
its mature form (Podivinsky et al., 1989), however the mechanism for processing has not yet
been elucidated.
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ACT1A    1 LPSYVDWRSAGAVVDIKSQGECGGCWAFSAIATVEGINKIVTGVLISLSEQELIDCGRTQ
ACT2A    1 LPDYVDWRTVGAVVGVKNQGLCSSCWAFSAVAAVEGINKIVTGNLISLSEQELVDCGRTQ
KFCp1    1 LPEMKDWRVSGIVSPVKDQGHCGSCWTFSTTGALEAAYKQAFGKGISLSEQQLVDCAGAF
KFCp2    1 LPESVDWRESGAVAPIKDQGSCGSCWAFSTVAAVEGVNQIATGEMIQLSEQELVDCDRTY
KFCp3    1 LPADFDWRDHGAVASVKNQGSCGSCWSFSTTGALEGANFLATGKLVSLSEQQLVDCDHEC
KFCp4    1 LPGSVDWREKGAVSPVKDQGQCGSCWAFSTISAVEGINQIVTGELISLSEQELVDCDKSY
KFCp5    1 GPTSLDWRKYGIVTGVKDQGDCGSCWAFSSTGAIEGINALANGDLISLSEQELVDCDST-
KFCp6 1 LPDSVDWREKGAVVGVKDQGSCGSCWAFSTIAAVEGINQIVTGDLISLSEQELVDCDTSY
*  #                              *
ACT1A   61 N-------TRGCNGGYITDGFQFIINNGGINTEENYPYTAQD-GECNLDLQNEKYVTIDT
ACT2A   61 I-------TKGCNRGLMTDAFKFIINNGGINTENNYPYTAKD-GQCNLSLKNQKYVTIDS
KFCp1   61 N-------NFGCSGGLPSQAFEYVKYNGGLDTEEAYPYTGKN-GECKFSSENVGVQVLDS
KFCp2   61 --------DAGCNGGLMDYAFEFIINNGGIDTEEDYPYRGVD-GTCDPERKNTKVVSIND
KFCp3   61 DPEEPGSCDSGCNGGLMNSALEYTLKAGGLMREEDYPYSGTDRGTCKFD-ETKIAASVAN
KFCp4   61 --------NMGCNGGLMDYGFQFIINNGGIDTEEDYPYRAVD-GTCDQFRKNARVVSING
KFCp5   60 --------NDGCEGGYMDYAFEWVMSNGGIDTETDYPYTGED-GTCNTTKEETKAVSIDG
KFCp6   61 --------NEGCNGGLMDYAFEFIIKNGGIDTEEDYPYNARD-GRCDQYRKNAKVVTIDD
* *
ACT1A  113 YENVPYNNEWALQTAVTY-QPVSVALDAAGDAFKHYSSGIFT-G-PCGT---AIDHAVTI
ACT2A  113 YKNVPSNNEMALKKAVAY-QPVSVGVESEGGKFKLYTSGIFT-G-SCGT---AVDHGVTI
KFCp1  113 -VNITLGAEDELKHAVAFVRPVSVAFQVV-NGFRLYKEGVYT-SDTCGRTPMDVNHAVLA
KFCp2  112 YEDVPPYDEMALKKAVAH-QPVSVAIEASGRAFQLYLSGVFT-G-ECGR---ALDHGVVV
KFCp3  120 FSVVSLDENQIAANLVKN-GPLAVAINAV--FMQTYVGGVSCPY-ICSK---RLDHGVLL
KFCp4  112 YEDVPEDDENSLKKAVAN-QPVSVAIEAGGRAFQLYESGVFT-G-HCGT---NLDHGVVA
KFCp5  111 YEDVAE-EESALFCAVLK-QPISVGIDGGAIDFQLYTGGIYD-G-DCSDDPDDIDHAVLV
KFCp6  112 YEDVPVNNEQALQKAVAN-QPVSVAIEASGMAFQFYESGVFT-G-NCGT---ALDHGVTA
*        #
ACT1A  167 VGYGTEG-------GIDYWIVKNSWDTTWGEEGYMRILRNVGG--AGTCGIATMPSYP--
ACT2A  167 VGYGTER-------GMDYWIVKNSWGTNWGESGYIRIQRNIGG--AGKCGIAKMPSYP--
KFCp1  170 VGYGVEN-------GVPYWLIKNSWGADWGDSGYFKMEMG-----KNMCGVATCASYP--
KFCp2  166 VGYGTDN-------GADHWIVRNSWGTSWGENGYIRMERNVVDNFGGKCGIAMQASYP--
KFCp3  173 VGYGSAGYAPIRMKEKPYWIIKNSWGESWGENGFYKICQG-----RNVCGVDSMVSTVAA
KFCp4  166 VGYGTEN-------GVDYWTVRNSWGPKWGENGYIKLERNINA-TSGKCGIASMASYP--
KFCp5  167 VGYGAES-------GEEYWIIKNSWGTDWGMKGYAYIKRNTSK-DYGVCAINAMASYP--
KFCp6  166 VGYGTEN-------SVDYWIVKNSWGSSWGESGYIRMERNTGA--TGKCGIAVEPSYP--
# *
ACT1A  216 -VKYNN
ACT2A  216 -VK-YT
KFCp1  216 -V--IA
KFCp2  217 -IKNGE
KFCp3  228 VHTTSN
KFCp4  216 -TKTGS
KFCp5  217 -TKESS
KFCp6  215 -IKTSQ
Figure 4: Alignment using T-Coffee (Notredame et al., 2000; Tommaso et al., 2011) of mature cysteine
proteases found in A. deliciosa in their mature forms (Nieuwenhuizen et al., 2007). Catalytically important
residues (#) and cysteine residues that are involved in disulfide bonds (*) are conserved among the different
isoforms.
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2.2 Protocols used to purify actinidin
Actinidin has been well characterised and there are well established methods for protein
purification that are used to obtain a purified sample. Actinidin is typically purified by
extracting the enzyme from the fruit of the Hayward cultivar from the A. deliciosa species
(GrK).  The Hayward cultivar is a popular choice to extract actinidin for several different
reason: the cultivar constituents 85% of the kiwifruit vines that are commercially grown
(Datson et al., 2011), the fruit has a high actinidin content when compared to other cultivars
(Maddumage et al., 2013), and the relative abundance of actinidin in the total soluble protein
in GrK is approximately 40% (Ciardiello et al., 2009). Actinidin has also been purified using
Ni-affinity chromatography after it was recombinantly expressed in Escherichia coli cells
(Nieuwenhuizen et al., 2007).
Anion exchange chromatography is a common technique that is used to purify actinidin from
GrK (Boland et al., 1972). The ACT1A actinidin isoform has a isoelectric point (pI) of 4.1
(Nieuwenhuizen et al., 2012), which enables actinidin to be separated from other kiwifruit
proteins that have different pI values (Maddumage et al., 2013). The ACT1A isoform is the
major acidic isoform in A. deliciosa, however there are 6 other isoforms that are expressed in
the kiwifruit that also have an acidic pI between the values of 3.7-4.7 (Table 2) and anion
exchange chromatography has previously shown that it can be used to purify the different
cysteine proteases in kiwifruit (Tello-Solis et al., 1995). The different isoforms showed
similarities between each other in their secondary structures (Tello-Solis et al., 1995),
however they have shown to have differences during enzymatic catalysis (Morimoto, 2002).
Table 2: Isoelectric point (pI) of actinidin, isoforms, and other cysteine proteases in A. deliciosa
(Nieuwenhuizen et al., 2007).
Isoform: ACT1A ACT2A KFCp1 KFCp2 KFCp3 KFCp4 KFCp5 KFCp6
pI: 4.1 8.6 4.7 4.1 4.6 4.3 3.7 4.0
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2.3 Results and Discussion
2.3.1 Purification of actinidin
Actinidin was purified from GrK kiwifruit to assess the structural and kinetic parameters of
actinidin. The protocol from Boland, et al (Boland et al., 1972) was modified to give better
consistency in the yields. For example, the ammonium sulphate concentration was increased
from 60% saturation to 80%. This amount was found to be the minimum to ensure that
actinidin was precipitating out of the solution every time, which was an important step  to
reduce the volume and remove any impurities that did not precipitate before anion exchange
chromatography was used.
The outer pericarp tissue of GrK was homogenised with phosphate buffer (100 mM, pH 6)
containing DTT and EDTA to produce a crude sample. This was centrifuged and the resulting
supernatant was decanted before solid ammonium sulphate was added to precipitate out the
soluble proteins. The precipitant was resuspended in a minimal amount of extraction buffer
(10-20 mL/ 100g of starting kiwifruit flesh) and injected onto a HiLoad™ Q HP anion
exchange column (GE Healthcare) after the column was exchanged into phosphate buffer (50
mM, pH 6). Actinidin was eluted from the column using a NaCl gradient of high salt buffer
and resulted with one peak (peak 1) eluting after approximately 206 mM (35 mS/cm) of the
salt had been added (Figure 5). A purified sample of actinidin was pooled from the fractions
containing the highest amount of protein (> 1000 mAU), as determined by the absorbance at
280 nm. The elution fractions under peak 1 had a considerably lower volume than what had
been injected onto the column, making the chromatography step a useful method for
concentrating the purified sample.
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Figure 5: Elution chromatogram of actinidin, injected onto a 5 mL HiLoad™ Q HP anion exchange column.
Elution was conducted by increasing the salt concentration (conductivity) with 0.5 M NaCl. The protein was
measured by its absorbance at 280 nm.
Actinidin purified using anion exchange chromatography was exchanged into a low salt
phosphate buffer by eluting the sample down a 120 mL HiLoad™ 16/600 Superdex™ 200 pg
size exclusion column (GE Healthcare) before the sample was analysed using analytical
ultracentrifugation (Figure 11). The protein eluted from the column as one peak (peak 1) at
approximately 95 mL, as monitored by the UV absorbance at 280 nm (Figure 6). There was
no aggregate present in the elutant and indicates that actinidin is stable in solution throughout
the purification.
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Figure 6: Elution chromatogram of actinidin eluting down a 120 mL HiLoad™ 16/600 Superdex™ pg 200 size
exclusion column. Protein was detected by its absorbance at 280 nm.
SDS-PAGE analysis was used to assess the purity of actinidin. Between 5-10 µg of protein
was taken from the different purification stages and the samples were loaded onto the gels
under reducing conditions. Actinidin migrated as a 26 kDa protein under reducing conditions,
in contrast under non-reducing conditions (data not shown). This is higher than its theoretical
molecular weight of 24 kDa (Nieuwenhuizen et al., 2007), however previous PAGE analysis
of actinidin has shown that reducing agents change how the protein migrates and that it is
common that actinidin runs as a higher molecular weight (Ciardiello et al., 2009). Actinidin
has three disulfide bonds (Baker, 1980) and the reducing agent is likely disrupting these,
which is affecting how the protein migrates during electrophoresis.
Multiple protein bands were present in the crude (lane 2), supernatant (lane 3), precipitant
(lane 4), and dialysis (lane 5) samples. Along with actinidin (26 kDa) there were bands that
corresponded to a 22, 18, and 16 kDa protein. These were hypothesised to be from the
Thaumatin-like protein (TLP) (Gavrovic-Jankulovic et al., 2002), kirola (D'Avino et al.,
2011), and KiTH, which is a peptide that is cleaved from kiwellin (Tuppo et al., 2008),
respectively. From these, the band representing TLP had the strongest intensity and this is
consistent with the abundance of TLP in kiwifruit compared to the other proteins (Ciardiello
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et al., 2009). Lane 6, that consisted of the fractions pooled from peak 1 (Figure 5) showed
that anion exchange chromatography can remove the 22 and 16 kDa  proteins and reduce the
amount of the 18 kDa protein, which is important for increasing the purity of the actinidin
sample.
Actinidin, purified by anion exchange chromatography (lane 6) was the most prominant,
however there were also the presence of lower molecular weight species that was eluted from
the anion exchange column. These bands were also present in lanes 4 and 5 but not present in
lanes 2 and 3 which was the crude and supernatant samples, respectively. It is hypothesised
that these bands represented the product of proteolytic digestion occurring throughout the
purification and that their low concentrations were responsible for the absence of absorbance
at 280 nm (Figure 5) and during mass spectroscopy analysis (Figure 8).
Figure 7: SDS-PAGE during the purification stages to isolate actinidin from GrK. The samples were run under
reducing conditions and contained between 5-10 µg of protein in each lane. lane 1: molecular marker, 2: crude
sample, 3: supernatant, 4: ammonium sulfate precipitation, 5: after dialysis, 6: pooled fractions from peak 1 after
anion exchange chromatography (Figure 5).
Actinidin retention at each step during the purification was quantified by measuring the
actinidin activity and protein concentration. The yield of actinidin dropped by 69% after the
anion exchange chromatography step, which can either be due to protein loss during the
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resulted in a 16% loss of yield between the crude and supernatant samples. Proteins in
kiwifruit have been shown to associate with the insoluble kiwifruit material (Ciardiello et al.,
2009) and this could have affected the amount of actinidin retained in this sample. The largest
loss of yield (43%) occurred after the protein had been precipitated using ammonium
sulphate. It is hypothesised that this is the result of the protein not re-suspending properly or
becoming denatured. To increase the concentration of the purified sample not all of the
fractions were pooled from peak 1 (Figure 5) and this would have contributed to the 10% loss
in yield that occurred during anion exchange chromatography.
Overall there was a reduction in total protein and this was correlated with an increase in the
specific activity. From 146 g of starting kiwifruit flesh 25 mg of actinidin was purified, which
is equivalent to 17 mg/ 100g. This is similar to other published values of 13.3 mg/ 100 g (M.
Grozdanovic et al., 2012) and 20 mg/ 100 g (Cavic et al., 2012). The specific activity of 39.5
µmol/min/mg is lower than the published values of 60 µmol/min/mg (K. Brocklehurst et al.,
1981) and 64 µmol/min/mg (Carotti et al., 1984), which also used CBZ-Lys-ONP as a
substrate. Actinidin can become inactivated during purification (M. Grozdanovic et al., 2012)
and this may have been occurring throughout the purification and resulting in a decrease in
specific activity.
Table 3: Purification table for the steps used to purify actinidin from 146 g of GrK flesh. The actinidin activity











Crude: 409 586 5.4 3164 100
Supernatant: 400 460 5.8 2669 84
Protein Ppt: 20 79 16.6 1308 41
IEX: 6 25 39.5 995 31
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2.3.2 Mass spectrometry
Electro-spray ionisation mass spectrometry (ESI-MS) was conducted to confirm the presence
of actinidin after it had been purified from GrK using anion exchange chromatography. The
mass spectrum shows a cluster of peaks between the mass values of 23,765.47 to 24,202.53
Da (Figure 8). This shows that the  data has come from a heterogeneous sample, and indicates
that there are multiple proteins present in the purified sample. The masses also do not
correlate with the molecular weight of 26 kDa after SDS-PAGE analysis (Figure 7, (lane 6))
and suggests that actinidin, under reducing conditions migrates differently during
electrophoresis.
The major peak at 23,802.22 Da (Figure 8) is predicted to represent the ACT1A isoform
(23809.3 Da) with an error of 7.08 Da (297 ppm). The mass of the other peaks, however did
not correlate to the theoretical mass of any of the other six identified cysteine proteases in A.
deliciosa (Table 4) with a similar, or lower error value and the masses are also different from
previous studies that purified actinidin from GrK that gave a mass of 23,883.1 Da using
MALDI-TOF mass spectrometry (M. M. Grozdanovic et al., 2014). It is hypothesised that
amino acid substitutions, extensions, or deletions are occurring in one or several of the
different isoforms. The mass differences in Table 4 were analysed to determine whether
truncations, incorrect processing of C- and N-terminal extensions (Nieuwenhuizen et al.,
2007), or amino acid substitutions were occurring, however the masses did not correlate. The
high heterogeneity of the sample may be responsible for the masses not aligning accurately
and therefore greater separation of the isoforms during anion exchange chromatography and
amino acid sequencing is required to confirm what sequence modifications are present.
20
Table 4: Theoretical mass of the actinidin isoforms expressed in A. deliciosa (Nieuwenhuizen et al., 2007) and
the difference between the theoretical masses and the experimental masses (Figure 8).
.
Isoform: ACT1A KFCp1 KFCp2 KFCp3 KFCp4 KFCp5 KFCp6

























43.83 -308.17 191.93 1104.33 -70.37 -26.67 -94.47
23,779.91 29.39 -322.61 177.49 1089.89 -84.81 -41.11 -108.91
23,802.22 7.08 -344.92 155.18 1067.58 -107.12 -63.42 -131.22
23,835.03 -25.73 -377.73 122.37 1034.77 -139.93 -96.23 -164.03
23,900.66 -91.36 -443.36 56.74 969.14 -205.56 -161.86 -229.66
24,002.38 -193.08 -545.08 -44.95 867.42 -307.28 -263.58 -331.38
24,069.31 -260.01 -612.01 -111.91 800.49 -374.21 -330.51 -398.31
24,104.75 -295.45 -647.45 -147.35 765.05 -409.65 -365.95 -433.75
24,202.53 -393.23 -745.23 -245.13 667.27 -507.43 -463.73 -531.53
Figure 8: Deconvoluted mass spectrum of the purified actinidin obtained after the anion exchange
chromatography purification step (Figure 5) at 1 mg/mL using ESI-MS. The masses of the major peaks are

















To understand how different pH environments affect the stability of actinidin, a thermal shift
assay was used over the pH range 3.7-9.3. The fluorescence of SYPRO® Orange increased as
the actinidin samples were exposed to an increase in temperature from 20 to 100oC, which is
indicative of the protein becoming unfolded (Figure 9). There was  a thermal shift in the
maximum fluorescence between the different conditions and this shows that pH is having an
effect on the thermal stability of actinidin.
The intensity of the fluorescence differed for each condition that was tested. At low pH (3.7,
4.7), the fluorescence intensity was larger than the fluorescence that occurred at high pH (8.7,
9.3), and implies that deprotonation is affecting the interaction(s) between the dye and the
protein. SYPRO® Orange interacts strongly with amino acids that have positively charged
side chains, such as lysine and arginine (Yue et al., 2003), and deprotonating these side
chains at high pH may be responsible for the decrease in fluorescence that is seen in Figure 9.
Figure 9: Thermal shift assay of the relationship between the thermal stability of actinidin to pH as measured by
differential scanning fluorimetry (DSF). Increase in fluorescence shows that actinidin is becoming unfolded as
the temperature is increased. The different pH environments (pH 3.7-9.3) are represented by the different
colours.
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A melting temperature (Tm) was obtained by calculating the midpoint of the fluorescence
transition from the data in Figure 9. The highest melting temperature was 71oC at pH 5.7
(Figure 10) and indicates that the phosphate buffer at pH 6 used in the purification protocol is
at an appropriate pH to stabilise actinidin in solution. At pH 6.7, the melting temperature was
lower (62oC) than that of a previous study, which measured a melting temperature of active
actinidin at pH 6.5 to be 73.9oC, using differential scanning calorimetry (M. M. Grozdanovic
et al., 2014). The study compared the thermal stability between active actinidin and actinidin
that had been inactivated by the E-64 inhibitor and showed that the inactive actinidin had a
lower melting temperature of 61oC when compared to the active form. This suggests that the
actinidin tested in Figure 9 could have been inactivated and this change is having a negative
impact on the thermal stability.
Figure 10: Melting temperature of actinidin, present in different buffers. Measurements were conducted in
triplicates and the standard deviation of the mean is represented by error bars.
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2.3.4 Analytical ultracentrifugation
The crystal structure of actinidin is monomeric (Baker, 1980) and to determine whether
actinidin was also a monomer in solution, the quaternary structure was assessed by measuring
the rate at which the protein sediments when a gravitational field is applied, during an
analytical ultracentrifugation (AUC) sedimentation velocity experiment (Figure 11). The
absorbance at 285 nm was used to measure the sedimentation of actinidin throughout the
AUC experiment (Figure 11 (a)) and the uniformity of the residuals (Figure 11 (b)) show that
the sigmoids, which are fitted to the data, represent the experimental data well. A c(M)
distribution was modelled using SEDFIT (Schuck, 2000), with the calculated frictional
coefficient of 1.14 and showed that there was a single peak present that had an integrated
mass of 23,862 Da (Figure 11 (c)). This indicates that at 0.3 mg/mL actinidin sediments as a
monodisperse species, which has a molecular weight similar to the theoretical molecular
weight of a monomer at 23,809 Da (Nieuwenhuizen et al., 2007) and this confirms that
actinidin is a monomer.
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Figure 11: Sedimentation velocity experiment of purified actinidin at 0.3 mg/ml in 50 mM phosphate buffer. A
sigmoid was fitted to the sedmentation data of actinidin (a) with the quality of the fit shown by the residuals (b).
A c(M) distribution of the data was modelled using SEDFIT (Schuck, 2000) and shows that the molecular
weight of actinidin in solution is 23,830 Da.
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2.3.5 Kinetics of actinidin
To determine the kinetic parameters of actinidin towards N-α-carbobenzoxy-L-lysine-p-
nitrophenyl ester (CBZ-Lys-ONP), the activity at increasing substrate concentration was
measured. The activity rate was plotted as a function of substrate concentration and was
shown to fit the Michaelis-Menten equation (Figure 12). From the fit of a hyperbola a Km
value of 37 µM and a Vmax value of 0.081 µmol/min was determined and a kcat value was
calculated to be 18.9 sec-1. The values for the kinetic parameters between actinidin and CBZ-
Lys-ONP have previously been calculated and are shown to differ from the values that were
obtained using the data from Figure 12 (Table 5: Comparison of the kinetic parameters, Km
and kcat for the catalysis of actinidin with CBZ-Lys-ONP between (Table 5). Inactivated
actinidin that might have occurred during protein purification and the presence of multiple
actinidin isoforms that can have different kinetic parameters (Morimoto, 2002) may be
factors which are contributing to the difference in values, however further investigation is
required.
Figure 12: Measurements of actinidin activity with varying concentrations of CBZ-Lys-ONP at pH 6.  A
Michaelis-Menten hyperbola curve was fitted to the data to identify the kinetic parameters Km and Vmax. Assays
were conducted in duplicates and the standard deviation of the mean is represented as error bars.
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Table 5: Comparison of the kinetic parameters, Km and kcat for the catalysis of actinidin with CBZ-Lys-ONP
between Figure 12 and previous studies.
Km (µM) kcat (sec
-1) Reference
37 18.9 Figure 12
22 29 (Boland et al., 1972)






The relationship between actinidin activity towards CBZ-Lys-ONP and pH was investigated
over a pH range of 1.9-8.6. Activity was seen to decrease in more acidic and basic
environments and the data resembled a bell-shaped curve with the highest activity occurring
between pH 5-7 (Figure 13). The activity-pH profile is consistent with previous studies (S.
Boyes et al., 1997; Sugiyama et al., 1997), which measured the activity of CBZ-Lys-ONP to
be at its highest between pH 5-7.
The loss of actinidin activity that occurred in acidic environments (pH 1.9-4), was considered
to be detrimental to the bioactive properties of actinidin, which increased gastric protein
digestion in a rat model (Montoya et al., 2014). However, actinidin has shown to increase the
digestion of some food proteins in an in vitro digestion assay, which is conducted at pH 1.9
(Kaur et al., 2010b) and therefore the loss of activity is more likely to be isolated to the assay
using the synthetic peptide derivative.
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Figure 13: Relationship between actinidin activity and pH using CBZ-Lys-ONP as a substrate. A pH range of
1.9-9 was formulated using citric (pH 1.9), citric-phosphate (pH 3.6-7.6), and tris-base (pH 8-8.6) buffers. The
data was modelled using a Gaussian distribution that was fitted to the data. Assays were conducted in duplicates
and the standard deviation of the mean is represented as error bars.
The background rate of CBZ-Lys-ONP hydrolysis in buffer, that was subtracted from the
activity rate, showed a pH dependence. As the pH increased above pH 6.6 there was an
exponential increase in the reaction rate of CBZ-Lys-ONP becoming hydrolysed (Figure 14).
The alkaline dependent hydrolysis shows that measuring the actinidin activity at pH 6 does
not induce competition for hydrolysing the substrate between actinidin and the buffer.
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Figure 14: Reaction rate between CBZ-Lys-ONP and buffers (pH 1.9-8.6) showing an exponential rate increase
at high pH. The assays were conducted with the buffers used in Figure 14 and did not contain any presence of
actinidin. Assays were conducted in duplicates and the standard deviation of the mean is shown as error bars.
2.4 Conclusions
2.4.1 Purification
Actinidin from GrK (Actinidia deliciosa cv. Hayward) was purified from other kiwifruit
proteins using anion exchange chromatography. The purified sample did not show any
aggregation, however it may have been partially inactivated. From 100 g of starting kiwifruit
flesh, 17 mg of protein was obtained, which is similar to previous studies (Cavic et al., 2012;
M. Grozdanovic et al., 2012).
The deconvoluted mass spectrum showed a cluster of peaks between 23,765.47 to 24,202.53
Da and it was hypothesised that, as well as the major acidic isoform, ACT1A other acidic
isoforms of actinidin (Nieuwenhuizen et al., 2007) had been purified. Further investigation,
including sequencing of the different peaks, is required to confirm this hypothesis.
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2.4.2 Characterisation
Actinidin, consistent to previous studies was a monomer in solution and both the thermal
stability and activity of actinidin towards the CBZ-Lys-ONP substrate was shown to be
influenced by pH. The melting temperature of 62oC at pH 6.7 was similar to the melting
temperature of inactivated actinidin at a similar pH, which has been described previously (M.
M. Grozdanovic et al., 2014). This indicates that the purified actinidin may be partially
inactivated. Inactivated actinidin could also explain why the kcat value of 18.9 sec
-1 was lower
than previous studies, (Boland et al., 1972; Lewis et al., 1988; Morimoto, 2002), however,
the different actinidin isoforms in the actinidin sample may also have contributed to this
value.
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Actinidin, as part of the CA clan, shares close structural similarities to papain (Rawlings et
al., 2012). The primary structure between actindin (PDB: 2ACT) (Baker, 1980) and papain
(PDB: 9PAP) (Kamphuis et al., 1984) aligns well and shows conservations of 103 residues,
including residues that are important for forming disulfide bonds and catalytically important
residues (Figure 15). The secondary structure folds also align well (rmsd= 0.484) between the
two cysteine proteases (Figure 16). Both structures are folded into two domains, termed L
and R. The L domain is dominated by α-helices while the R domain is characterised by an
anti-parallel β-sheet, which is centred between two surface α-helices. The active site of
papain and actinidin is located in the cleft between the two domains. Aligning 86 residues,
which constitute the active site including, Cys-25, His-162, and Asn-182 residues (Figure 16
(b)) aligned very well (rmsd= 0.294) (Kamphuis et al., 1985). This indicates that the
mechanism of catalysis is conserved between actinidin and papain.
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Actinidin    1 LPSYVDWRSAGAVVDIKSQGECGGCWAFSAIATVEGINKITSGSLISLSEQELIDCGRTQ
Papain       1 IPEYVDWRQKGAVTPVKNQGSCGSCWAFSAVVTIEGIIKIRTGNLNQYSEQELLDCDRR-
*  #                              *
Actinidin   61 NTRGCDGGYITDGFQFIINDGGINTEENYPYTAQDGDCDVALQDQKYVTIDTYENVPYNN
Papain      60 -SYGCNGGYPWSALQLVA-QYGIHYRNTYPYEGVQRYCRSREKGPYAAKTDGVRQVQPYN
*                                *
Actinidin  121 EWALQTAVTYQPVSVALDAAGDAFKQYASGIFTGPCGTAVDHAIVIVGYGTEGGVDYWIV
Papain     118 QGALLYSIANQPVSVVLQAAGKDFQLYRGGIFVGPCGNKVDHAVAAVGYGP----NYILI
*     #
Actinidin  181 KNSWDTTWGEEGYMRILRNVGGA-GTCGIATMPSYPVKYNN
Papain     174 KNSWGTGWGENGYIRIKRGTGNSYGVCGLYTSSFYPVK--N
#                        *
Figure 15: Sequence alignment of actinidin (PDB: 2ACT) (Baker, 1980), and papain (PDB: 9PAP) (Kamphuis et
al., 1984) by T-Coffee (Notredame et al., 2000; Tommaso et al., 2011). Conserved residues are highlighted in
black and residues involved in disulfide bonds (*) and residues important for catalysis (#) are indicated.
Figure 16: Structural alignment of actinidin (2ACT) (Baker, 1980) and papain (9PAP) (Kamphuis et al., 1984),
shown in green and blue, respectively, depicting both the L and R domains (a) and catalytically important
residues, such as (actinidin numbering): CSD-25 (Cys-25 present in oxidised form), His-162 and Asn-182 in the
active site cleft (b).
3.1.2 Catalytic function
The catalytic reaction of cysteine protease enzymes is a multi-step process that results in
peptide bond cleavage, and the formation of two products as shown in Equation 1. An
(b).(a).
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enzyme substrate complex (ES) initially forms by a catalytically active cysteine residue (Cys-
25 in actinidin) (Baker, 1980) binding to the peptide substrate. The ES complex is known as
an acylenzyme intermediate and at this stage the first product (P1) is released. A hydrolysis
reaction subsequently allows the second product (P2) to be released and this step also
regenerates the enzyme for further peptide cleavage (Keith Brocklehurst et al., 1987).
In actinidin, the catalytic mechanism has been investigated and been found to differ slightly
from papain. A higher catalytic efficiency has been shown in actinidin for synthetic peptide
derivatives that have aliphatic moieties when compared to substrates with aromatic moieties,
in contrast to papain (Baker, 1980). Subsequent molecular dynamic simulations have
suggested that the binding affinities for peptides and the constraint for product diffusion, due
to a salt bridge that is unique to actinidin, are responsible for the lower catalytic efficiency for
the substrates that have aromatic moieties in actindin (Reid et al., 2001). These same
differences in the composition of amino acids in the active site may be the reason why
actinidin has shown a higher caseinolytic activity at lower pH, when compared to papain (M.
Ha et al., 2013), which has important implications for the bioactive properties (Kaur et al.,
2010a, 2010b) and biotechnological applications (Katsaros et al., 2010) that actinidin is
involved in.
Equation 1: Reaction schematic of cysteine proteases involving peptide bond cleavage and the formation of two
products (Keith Brocklehurst et al., 1987).
3.2 Catalytic inactivation of cysteine proteases
The catalytic activity of a cysteine protease can inactivate and this has been correlated with
the susceptibility of a catalytically important cysteine residue towards oxidative reactions. In
papain and actinidin, a cysteine residue important for catalysis (Cys-25) is positioned in the
active site cleft between the two domains (Baker, 1980; Kamphuis et al., 1984). This residue
sticks out away from the enzyme and exposes the thiol functional group of the amino acid to
the surrounding solution (Figure 17).
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Figure 17: Surface structure of (a) papain (PDB: 9PAP) (Kamphuis et al., 1984) and (b) actinidin (2ACT)
(Baker, 1980) . The catalytically important cysteine  residue (Cys-25), in which the thiol group has been
modified to a sulfinic acid is depicted as a green residue in the active site cleft of each protease.
Exposed thiol groups can react readily with oxygen-containing compounds, especially when
the sulfur atom is deprotonated, and will form oxygen derivatives, such as sulfenic (RSOH),
sulfinic (RSO2H), and sulfonic (RSO3H) acid (Reddie, 2008). These modifications of the
thiol groups can have important implications in biology, for example a 67% activity loss was
measured when papain was incubated with hydrogen peroxide (Lin, Armstrong, et al., 1975).
Similarly the addition of the reactive oxygen species, such as superoxide (Offer et al., 1998)
and hydroxyl radicals (Lin, Clement, et al., 1975) as well as vitamin C (Ozawa et al., 1962),
oxygen (Nagaoka et al., 2005), and nitric oxide (Xian et al., 2000) have all been measured to
inactivate papain. The reaction between hydrogen peroxide and papain was correlated with a
loss of sulfhydryl groups and the inactivation was found to be reversible when a reducing
agent was added (Lin, Armstrong, et al., 1975). Because the cysteine residue at position 25
represents the only free cysteine sulfhydryl group in papain (Kamphuis et al., 1984) thiol
oxidation of this cysteine residue is probable and likely to be responsible for the observed
inactivation. A reaction schematic showing the reversible oxidation reaction with papain has
been proposed (Armstrong et al., 1978) and shows that hydrogen peroxide reacts with the
thiol group to form a sulfenic acid, which can be reduced when another thiol-containing
compound (reducing agent) is added, as shown in Equation 2. The susceptibility of cysteine
proteases to oxidation reactions has made it necessary for researchers to purify these enzymes




Equation 2: Reaction schematic of reversible inactivation of papain with hydrogen peroxide and a thiol-
containing species (Armstrong et al., 1978).
3.3 Results and discussion
3.3.1 Time-based activity loss
Kinetic analysis of the specific activity of actinidin in Actazin™ revealed that the activity
decreased over time. Activity measurements were conducted immediately after the kiwifruit
powder was solubilised in phosphate buffer (100 mM, pH 6) at a concentration of 100 mg/mL
and centrifuged to separate the solution from the insoluble kiwifruit material. The rate of
activity loss over 120 minutes was fitted to an exponential curve (R2= 0.92), which better
represented the data than a linear fit (R2= 0.87) and showed an activity loss of 63% between
time 0 and 120 minutes of incubating the sample at room temperature (Figure 18).
During the first 10 minutes there was a 23% decrease in activity and this indicates that the
inactivation occurs rapidly. It is hypothesised that a chemical species in the kiwifruit powder
is inactivating actinidin. The rapid nature of the inactivation suggests that this inactivator is
present at high concentrations in the solution or that there is a collection of molecules that
inhibit actinidin activity and collectively is present in a high concentration. Because the
inactivation occurs rapidly the activity at time 0 may not accurately reflect the initial actinidin
activity before it is inactivated. This could have implications for the quality control tests for
actinidin activity in the different kiwifruit powder batches that are conducted by Anagenix
Ltd, and therefore warranted further investigation.
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Figure 18: Exponential loss (R2= 0.92) of actinidin activity after the kiwifruit powder was solubilised in
phosphate buffer, centrifuged and assayed with CBZ-Lys-ONP every 5 minutes. The sample used to test for
actinidin activity was stored at room temperature throughout the experiment.
The time-based inactivation of actinidin in kiwifruit powder (Figure 18) is not observed in the
purified actinidin samples. Actinidin purified from GrK was assayed over a time span of 120
minutes while the sample was similarly incubated at room temperature. The linear regression
fit showed that there was little decrease between time 0 and after 120 minutes of incubation
(Figure 19). This suggests that there are compounds in the kiwifruit powder that are
responsible for the inactivation. One difference between the purified actinidin and kiwifruit
powder was that the purification protocol purified actinidin under reducing conditions,
analogous to previously published protocols (K. Brocklehurst et al., 1981). It was therefore
hypothesised that an oxidant in the kiwifruit powder when it is solubilised in buffer is having
an effect on the activity of actinidin.
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Figure 19: Linear fit of the change in actinidin activity from a purified sample when incubated at room
temperature.
3.3.2 Reversible inactivation with reducing agents
The activity loss that is occurring when actinidin is inactivated can be reversed in the
presence of a reducing agent. Kiwifruit powder was solubilised at a concentration of 100
mg/mL in phosphate buffer (100 mM, pH 6) and centrifuged. The supernatant was
immediately assayed and then assayed every 30 minutes thereafter for 120 minutes. This
represented the control and was replicated for the three samples. After the control had been
measured for each sample a reducing agent (cysteine, DTT, or β-mercaptoethanol) was added
to the cuvette at a concentration of 5 mM. The enzyme was incubated with the reducing
agent, in buffer, for 2 minutes before the assay commenced. The actinidin activity for all
control samples inactivated at an exponential rate (Figure 20 (a-c)). The decay is similar to
what was observed previously (Figure 18), however the inactivation rates were different
among the different samples and this could be the result of insufficient solubilisation of the
kiwifruit powder in buffer.
Inactivated actinidin activity was reactivated over the 120 minutes in all three samples after
the respective reducing agent was added indicating that oxidation is likely to be the cause of
inactivation (Figure 20 (a-c)). The most effective reducing agent at protecting actinidin from
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becoming inactivated over 120 minutes was cysteine. This was followed by samples
containing DTT and β-mercaptoethanol (Figure 20 (d)). The reducing agents, however, did
not completely restore the activity across the 120 minutes as shown by the negative gradient
of the data (Figure 20 (a-c)). This indicates that either the reduction reaction needed a longer
incubation period than 2 minutes in order to reactivate actinidin or that the inactivation is
partially irreversible.
Figure 20: Reversible inactivation of actinidin in kiwifruit powder upon the addition of 5 mM cysteine (a), DTT
(b), or β-mercaptoethanol (c). The slope of the linear decrease the reducing agent was added to the cuvette (d)
shows the effectiveness of the reducing agent at maintaining activity over 120 minutes.
Inactivation of papain by oxidation has been well characterised and it is hypothesised that
actinidin similarly becomes oxidised when the kiwifruit powder is solubilised in phosphate
buffer. Papain has been shown to be reversibly inactivated with hydrogen peroxide (Lin,
Armstrong, et al., 1975) and the catalytically active cysteine residue was shown to be affected
by the inactivation, by measuring the free sulfhydryl groups. As illustrated above (Figure 16),
actinidin has a homologous catalytically active cysteine residue in the active site (Figure 16)
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and this residue is also exposed to solution in the active site cleft (Figure 17). In support of
this, the crystal structure of actinidin shows a partially oxidised Cys-25 residue (Figure 16).
The vulnerability of Cys-25 and generally known sensitivity of thiol groups to oxidation (Luo
et al., 2005) makes Cys-25 a plausible target for biological oxidation. Whilst hydrogen
peroxide-induced oxidation is used as a model system to explore oxidation processes in vitro
on purified enzymes the exact mechanism of oxidation with the kiwifruit powder has not
been determined. A proposed mechanism for this reaction given in Equation 2, which
produces a catalytically inactive sulfenic group that can be reversed back to a catalytically
active thiol group upon addition of a reducing agent such as cysteine. An alternative
mechanism could, however involve non-oxidative reactions, such as conjugate addition and
disulfide bond formation of Cys-25 that is similarly reversible by the addition of cysteine.
Either of these reactions would explain the results shown in Figure 20, of reversible
inactivation after a reducing agent is added. The inability to completely restore the activity
with the reducing agents also suggests that a fraction of the actinidin is becoming irreversibly
inactivated or is not reactivating after the 2 minute incubation period. This may mean that the
oxidative inactivation reaction is more complex and leads on to other oxidation reactions,
which has been shown previously by reacting hydrogen peroxide with thiol-containing
compounds (Luo et al., 2005). Hydroxyl and superoxide radicals may also be present in the
solution and these have similarly been shown to react with sulfhydryl containing enzymes to
induce irreversible inactivation (Armstrong et al., 1978). A model for the possible pathways
that lead to actinidin becoming denatured or inactivated through oxidation reactions is
summarised in Figure 21.
Figure 21: Model for the loss of actinidin activity measured over 120 minutes after kiwifruit powder is
solubilised in phosphate buffer showing how the different oxidation states can determine whether the
inactivation is reversible or irreversible.
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3.3.3 Concentration dependent activation
Various concentrations of cysteine were trialled to understand whether the protective effect
that reducing agents had would last for an extended period of time. Samples were incubated
at room temperature with the presence of cysteine at a concentration of 1-40 mM for 30
hours. The activity measured approximately every 5 hours showed that a concentration of
cysteine below 5 mM did not protect actinidin within the maximal range of 14-15
µmol/min/mg while above 5 mM cysteine did protect actinidin, however over time the
effectiveness was reduced (Figure 22). This indicates that at a kiwifruit powder concentration
of 100 mg/mL a cysteine concentration of at least 5 mM is needed to prevent any unwanted
inactivation. The inactivation over time also indicates that the chemical species that
inactivates actinidin may only be partially blocked with the reducing agents or that incubating
the samples over time, at room temperature, is sufficient to form more inactivating species.
This is consistent with the model of inactivation proposed where inactivation can move
between reversible and irreversible states (Figure 22). The difference in the initial rates for
the samples that contained a high cysteine concentration is hypothesised to be due to a
mixing error or errors in subtracting the background rate, however it may simply be due to a
more complex reaction system that is occurring with the addition of high cysteine
concentrations to the sample.
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Figure 22: Actinidin activity change over 30 hours in the presence of cysteine at varying concentrations (1-40
mM). Standard deviation between replicates is shown as error bars.
The substrate, CBZ-Lys-ONP was shown to react with reducing agents in a concentration
dependent manner. Upon addition of a reducing agent CBZ-Lys-ONP is hydrolysed,
resulting in an increase in absorbance at 348 nm. This reaction is linear with respect to the
concentration of the reducing agent (Figure 23). Cysteine appears to be the most effective at
hydrolysing the substrate, and is followed by DTT and β-mercaptoethanol, and this also
correlates with the effectiveness of reducing agents at reactivating actinidin after it had
become oxidised (Figure 20). This reducing agent-promoted reaction that is occurring in the
absence of actinidin was subtracted from activity measured in samples that contained
reducing agents and  actinidin to prevent any inaccuracies.
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Figure 23: Linear fit for the reaction rate of CBZ-Lys-ONP with increasing concentrations of reducing agent
(cysteine, DTT, or β-mercaptoethanol). Standard deviation between replicates are shown as error bars.
3.3.4 Effect of vitamin C on actinidin activity
The absence of inactivation in the purified actinidin sample (Figure 19) suggests that the
oxidant responsible for inactivation is specific to the kiwifruit powder. Two components in
kiwifruit were investigated to determine whether they were able to inactivate purified
actinidin and therefore responsible for the inactivation occurring in the kiwifruit powder. The
components investigated were vitamin C and dissolved oxygen. Kiwifruit have high levels of
vitamin C (USDA, 2011) and vitamin C can be readily oxidised to dehydroascorbic acid and
hydrogen peroxide. Dissolved oxygen in the phosphate buffer may also provide the catalyst
for oxidation reactions, such as vitamin C oxidation that produce reactive oxygen species
which can inactivate actinidin.
To investigate the effects of vitamin C on actinidin activity vitamin C, at a concentration
between 1-100 mM, was added to a cuvette that contained active actinidin. No reducing
agents were present in the reaction to protect actinidin from oxidation. With an increase in
vitamin C concentration the specific activity of actinidin exponentially decreased (R2= 0.99)
(Figure 24). This decrease was accentuated when the cuvette, containing vitamin C and
actinidin, was incubated in an aerobic environment for 5 minutes, prior to being assayed.
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Vitamin C-induced inactivation upon incubation has been previously reported for papain
(Fukal et al., 1984; Ozawa et al., 1962), and the inactivation of papain by vitamin C was
further shown to be dependent on aerobic conditions. The mechanism of inactivation was
hypothesised to be due to the formation of reactive oxygen species, such as hydrogen
peroxide and hydroxyl radicals during vitamin C oxidation. This hypothesis was supported by
showing that catalase, which neutralises hydrogen peroxide, partially prevented the vitamin
C-induced inactivation (Kanazawa et al., 1994). While vitamin C has been shown to
inactivate papain, it is unclear whether it has the same effects on actinidin. A previous study
has shown that vitamin C at concentrations of 0.8-3.2 mM actually increased the activity of
actinidin (Minh Ha et al., 2014), which is in contrast to the results in Figure 24. The
concentration of vitamin C used in this experiment is substantially higher (> 104) than the
physiological ratio of vitamin C and actinidin in GrK. This indicates that vitamin C,
regardless of whether or not it inactivates actinidin, is most likely not responsible for the
exponential loss of actinidin activity seen (Figure 18). The oxidation reaction that inactivates
actinidin, however, could be a collective sum of reactions caused from a number of different
species, which may include vitamin C.
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Figure 24: Exponential loss of actinidin activity after 1-100 mM of vitamin C was added. Sample containing
vitamin C and actinidin were either assayed immediately, or incubated at room temperature for 5 minutes before
the assay commenced. Standard deviation between the replicates is shown as error bars.
3.3.5 Effect of oxygen on activity
Oxygen that was produced from endoperoxidases has been shown to affect the activity of
cysteine proteases in previous studies (Nagaoka et al., 2005) and it was hypothesised that the
phosphate buffer, which contains oxygen, may be responsible for inactivating actinidin in the
kiwifruit powder. The experiment conducted to test this hypothesis measured the activity of a
purified actinidin sample in phosphate buffer (50 mM, pH 6) that had or had not been
degassed. The measure of dissolved oxygen before and after degassing was 106% and 56%,
respectively, after the probe was calibrated against tap water, which provided contrasting
assay conditions. The activity measurement for actinidin did not show a significant change (p
> 0.05) in the two different buffers, which disagreed with the predicted hypothesis. The
difference between the initial activity and after the enzyme was incubated in phosphate buffer
for one hour, was also non-significant (p > 0.05) for either the oxygen saturated and
moderately saturated buffers (Figure 25 (a)). Water, saturated with oxygen, has been reported
to form reactive oxygen species such as hydrogen peroxide and hydroxyl radicals under the
influence of visible and infrared radiation (Gudkov et al., 2012), however these conditions
are more forcing than those used in the current study, or the conditions that the actinidin
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powder would reasonably be exposed to during processing. The current study indicates that
these radicals are not forming by showing that oxygen mediated inactivation is not
significant.
The addition of vitamin C resulted in inactivation, which increased after incubation (Figure
25 (b)), consistent with previous results (Figure 24). The increase in dissolved oxygen did not
have a large impact on the inactivation that was occurring in the presence of vitamin C. This
indicates that the inactivation seen with vitamin C is not correlated with the concentration of
dissolved oxygen. The results in Figure 25 imply that the dissolved oxygen in the phosphate
buffer is not causing an effect on the inactivation of actinidin in buffer.
Figure 25: Effect of dissolved oxygen on actinidin activity. The super saturated oxygen buffer (106%) sample is
shown in dark green. The moderately saturated oxygen (56%) buffer is shown in light green. Samples were
assayed at time 0 and after one hour (a). 20 mM of vitamin C was added to the sample after incubation for one
hour and assayed immediately or after the vitamin C was incubated with actinidin for 5 minutes (b). Standard
deviation between the replicates is shown as error bars.
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3.4 Conclusion
3.4.1 Inactivation of actinidin
Upon solubilising the kiwifruit powder, actinidin activity is lost over time. The inactivation is
most prominent at the start of the time measurement with 23% of activity lost within the first
10 minutes, and continues thereafter to a 63% drop after 120 minutes. Actinidin, purified
under reducing conditions does not show the activity loss and this leads to the hypothesis that
the oxidation state of actinidin is important for the retention of activity in solution and that
components of the pulp are involved in the inactivation. The inactivation is reversible when a
reducing agent, such as cysteine, DTT, or β-mercaptoethanol was added, and this supports the
hypothesis.
3.4.2 Mechanism of inactivation
The inactivation of actinidin was characteristic of the inactivation of cysteine protease
homolog, papain and this supports the hypothesis that inactivation is caused by the formation
of reactive oxygen species in the solution. The mechanism for generating the oxygen species,
such as hydrogen peroxide, superoxide, and hydroxyl radicals is, however unclear. The
magnitude of inactivation that is occurring in Figure 18 was anticipated to be driven by a
chemical that is either highly reactive and specific or is present in high concentration in the
sample. Vitamin C occurs in kiwifruit at high concentration and has previously been shown to
inactivate papain (Fukal et al., 1984; Ozawa et al., 1962). This may be due to the formation
of reactive oxygen species after vitamin C becomes oxidised. The results from Figure 24
showed that actinidin is inactivated by vitamin C, which is similar to papain. The inactivation
from vitamin C is concentration dependent, however the concentrations are much higher than
the physiological level found in kiwifruit. This makes it improbable that vitamin C is solely
responsible for the inactivation. Vitamin C could still be contributing to a combined effect.
Dissolved oxygen in the buffer was also determined not to inactivate actinidin, despite
previous studies showing that cysteine proteases can be inactivated by oxygen (Nagaoka et
al., 2005). A number of oxidising agents present in kiwifruit powder may be oxidising or
reacting with the active site Cys-25 residue when the powder is solubilised, which results in




The inactivation of actinidin may have implications for the quality control of different
batches of the kiwifruit powder. The protocol for the quality control tests does not use a
reducing agent and therefore could be affected by inactivation occurring with the onset of
powder solubilisation. It is recommended that a reducing agent, such as cysteine, be included
in the routine quality control assays and that the concentration of the reducing agent be 5 mM
or more, with appropriate subtraction of the background rate, in order to provide sufficient
protection from actinidin inactivation.
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4 Chapter Four : Actinidin Retention
during Kiwifruit Processing
4.1 Introduction
4.1.1 Processed fruit products
Harvested fruit, that are not consumed as fresh fruit, can be processed to form fruit-derived
products which are sold in the health-food, beverage, and cosmetics industries. The processed
fruit have qualities that make them suitable for an intended product. For example processing
technologies can prevent the fruit from perishing from microbial, enzymatic activities, and
oxidation reactions (Rodrigues et al., 2012), which result in increased shelf life of the
product, flavour and colour retention, and reduced food safety risk. Processing technologies
are also used to change the aesthetics of the fruit and allows the processed product to be
readily accessible and easy to use or consume.
There is a wide selection of technologies that exist to process fruits, which have varying
affects on the nutritional, organoleptic, and textural properties of the fruits in different ways.
Choosing one technology over another requires balancing the effects that the processing has
on the quality of the product with the cost, safety, and through-put capacity of the operation.
Spray-drying and freeze-drying are commonly used for dehydration, with spray-drying being
the more cost effective practice. Both technologies reduce the moisture content of the fruit;
however the impacts on the nutritional value, structural integrity, and biological function
makes freeze drying a more sensitive technology that results in a final product that is
regarded as higher quality (Sagar et al., 2010). Currently, Actazin™ powder is produced by
the dehydration of fresh kiwifruit pulp using a minimal freeze-drying processing practice.
4.1.2 Loss of bioactive molecules during processing
Processing of fruit offers significant benefits by increasing product storage life but can also
have a negative impact on the bioactive molecules in fruits that are important for health. The
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act of fruit processing exposes the bioactive molecules to both internal factors from within
the fruit and external factors from the surrounding environment of the fruit. These internal
factors that affect the retention of bioactive molecules involve chemical reactions that affect
retention of bioactive molecules. Processing fruit, such as by pulping, disrupts the fruit
structure to release its cellular components. The biomolecules become exposed to interactions
that were not normally encountered whilst the cell was intact and this may increase the
chance of detrimental reactions to the bioactive compounds. The bioactive molecules can be
damaged by physical external factors, such as heat, light, pressure, and oxygen. For example,
vitamin C, an important antioxidant molecule is susceptible to both heat and oxidation
reactions (Riaz et al., 2009) and this reduces the protection the molecule can provide against
reactive oxygen species. Proteins are also affected by processing with freezing, thawing, and
drying stresses affecting the protein hydration shell that is important for its structural stability
(Arakawa et al., 2001). These have direct consequences on the retention of enzymatic activity
after processes, such as freeze drying, that expose enzymes to these stresses (Carpenter et al.,
1987; Matsubara et al., 2006).
The enzymatic activity of the bioactive protein, actinidin, which is an important component
in Actazin™ could be affected by the processing of kiwifruit. Actinidin activity has been
found to increase the digestion of food proteins in a digestive tract environment in vitro (Kaur
et al., 2010a, 2010b) and therefore a maximal amount of active actinidin is desired in the
Actazin™ product, that is sold as a digestive aid. Routine quality control checks performed by
Anagenix, Ltd, however found that the actinidin activity varies 48% between the highest and
lowest actinidin containing batches of kiwifruit powder (Figure 26). Kiwifruit, as a biological
material, is expected to display some variability as a result of the initial harvest and ripening
process, and the processing of kiwifruit to produce Actazin™, which involves several
transformation stages such as ripening, pulping, and freeze drying. As Anagenix Ltd desires a
maximal amount of actinidin in Actazin™, variations introduced during processing warrants
further investigation.
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Figure 26: Activity rates of actinidin in different batches of kiwifruit powder measured as routine quality control
checks by Anagenix Ltd.
4.1.3 Pre- and post-harvest factors that affect the composition of fruits
Pre-harvest factors
Pre-harvest factors influence the growth of plants and can have important contributions to the
quality of the fruit. Pruning, which is conducted throughout the growing season has been
associated with an increase in soluble solids content (Gerasopoulos et al., 2005), as well as
fruit yield in kiwifruit orchards (Miller et al., 2001). Other growing practices, such as
spraying, also impacts the composition of kiwifruit. Treating the fruit with a 1% solution of
calcium chloride four times during fruit development resulted in the fruit increasing its
firmness and calcium content, which had a positive effect on fruit storability (Gerasopoulos et
al., 2005). Similarly, a synthetic plant hormone that was sprayed at a low dosage (4 µL/L)
before flowering increased the fruit weight, soluble solids content, vitamin C, and other key
indicators of nutritional quality (Cruz-Castillo et al., 2014). Water, temperature, and light
stresses have all been shown to have an effect on the composition of grapes, including the
accumulation of secondary metabolites in berry pulps, seeds, and skins as the plant responds
to the stress (Ferrandino et al., 2014). These examples show that pre-harvest factors can
influence the development of fruit leading to changes in the composition of the fruit.
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Fruit growth
Fruit growth is also important and has been shown to play an essential role for protein
development in kiwifruit. From a point 100 days before the commercial harvest start date
until harvest the protein content increases approximately 200 fold in GrK fruits (Ciardiello et
al., 2009). The protein concentration, reaches the highest amount when harvested, and
appears to plateau for at least 40 days. The ratio of the individual soluble proteins present was
measured by densitometry of the protein bands that migrated during SDS-PAGE analysis.
Actinidin, from GrK kiwifruit had a high relative abundance compared to the other soluble
proteins and remains consistently high during the harvest season (Ciardiello et al., 2009).
Actinidin activity continually increased during fruit growth until the date that harvest
typically commences (S. Boyes et al., 1997). These results indicate that, over the harvest
period, the protein content is high and this also correlates with high actinidin activity.
Post-harvest ripening
Post-harvest ripening allows fruit to develop to more desirable composition and this may also
have an effect on the actinidin content. Northern analysis reported actinidin expression levels
decreased after the A. deliciosia fruit was ripened with ethylene (Nieuwenhuizen et al.,
2007). Contrary to this result, the same study measured the protein levels using western
analysis and showed there was no significant change in actinidin levels. In support of the
latter, the actinidin activity increased when the fruit was ripened with ethylene, however the
activity did sharply decline if the fruit was over ripened (S. Boyes et al., 1997).
Fruit storage
Fruit storage is an important practice that is used to control the ripening of fruits. Kiwifruit
stored for 182 days at 0-0.5oC, with a relative humidity of 90-95%, showed a steady increase
in sugar content, soluble solids, and vitamin C as well as a decrease in fruit firmness and total
acidity (Bonvehi et al., 1997). The respiration rates of harvested fruits affects the rate at
which a fruit ripens by breaking down carbohydrates, and kiwifruit in cool storage have
reduced respiration rates, which would delay ripening (Ritenour et al., 1999). Storage at 4oC
had no substantial effect on actinidin activity during a 2 month period, in fact, the activity
slightly increased, which may have been from the fruit ripening (S. Boyes et al., 1997).
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4.1.4 Aims
This chapter aims to identify any factors during Actazin™ production that has an effect on the
actinidin activity which may contribute variations observed in kiwifruit powder batches
(Figure 26). The factors that affect actinidin retention throughout the production could occur
both pre- and post-harvest. Pre-harvest factors affect the growth and maturity of fruits
ultimately picked. Post-harvest factors can affect the ripeness of the fruit, with the
development and retention of protein levels influenced by processes involved in
transformation of the kiwifruit from a fruit to a powder. Actinidin activity was measured at
different stages of the processing line in order to optimise Actazin™ production so that
maximal content of actinidin is present in the final product.
4.2 Results and discussion
4.2.1 Activity variation between individual kiwifruits
To explore the variation in actinidin activity between individual kiwifruit that is caused by
pre-harvest factors the specific activity of six kiwifruit, which were representative fruit that
would be pulped at Kiwifruit Processing Company Ltd, was measured. The flesh of each
kiwifruit was homogenised, centrifuged, and the resulting supernatant was assayed as
described in Chapter 2. The specific activities of the kiwifruit fell around the median value of
8.2 µmol/min/mg, however there were outliers that had a specific activity above and below
this value (Figure 27 (a)). The data was assessed to understand whether the specific activity
variations represented the expected variation in a normal distribution using a Q-Q plot.  The
data using six kiwifruit fits a normal distribution (Figure 27 (b)) and indicates that while pre-
harvest factors introduces variation, that this is normal. Therefore we can assume that the
actinidin activity between pulped kiwifruit batches should all be similar, although further
testing between pulped kiwifruit batches at the Kiwifruit Processing Company Ltd is
recommended.
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Figure 27: Activity variation between six individual kiwifruit represented by a (a) box and whisker plot (a) and
(b) Q-Q plot.
4.2.2 Post-harvest storage effects on activity
Kiwifruit is commonly kept in cool storage to prevent the fruit from degrading. The effects
cold storage had on actinidin activity was assessed by comparing the specific activity of
recently harvested fruit and fruit after an additional 4-5 months of cool storage. Both samples
were taken from bins of kiwifruit that had been ripened and were about to be pulped,
however the samples sent down from Tauranga after the extended cool storage period were
heavily bruised. The comparison (Figure 28) showed on average 73% of activity was retained
after the extended cool storage. The standard deviation of the fruit sample "after storage" was
considerably higher than that of the sample "before storage" (Figure 28). An explanation for
this variance is that the fruit was individually assayed unlike the fruit that was assayed for the
"before storage" sample, which was homogenised. The variance, however could have also
been caused by the condition of the fruit as they were considerably bruised. More fruit
samples will be needed to understand whether the bruising was having an effect or not.
Overall, however the cool storage did not substantially reduce the actinidin activity which is
consistent with previous studies (S. Boyes et al., 1997).
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Figure 28: Actinidin activity before and after 4-5 months in cool storage. Four kiwifruit were homogenised
together for the "before storage" sample and standard deviation between the reps is shown as error bars. Nine
individual fruit was assayed for the "after storage" samples and the standard deviation between these samples is
shown as error bars.
4.2.3 Post-harvest ripening effects on activity
Post-harvest ripening of kiwifruit has previously been shown to be important for the actinidin
activity (S. Boyes et al., 1997). Kiwifruit that arrives at the Kiwifruit Processing Company
Ltd is stored in different facilities that manage how the fruit ripens. Initially the fruit is stored
at 0oC to retard ripening and this storage stage is utilised to control the amount of kiwifruit
that is ready to be processed into pulp ("pre-process"). The fruit is moved to ambient
temperature (~12-15oC), which allows the fruit to ripen before being refrigerated (4oC) until
they are ready to be processed into a pulp ("process-ready"). Throughout the ripening, the
fruit is graded to remove any fruit that appears to be over-ripe or has become spoiled from
microbial contamination ("past-process").
Fruit samples at each of these stages were assessed for specific activity and showed that the
ripening process, conducted at Kiwifruit Processing Company Ltd is important to achieve a
high activity of actinidin. Between "pre-process" and "process-ready" samples there was a
highly significant increase in average specific activity of 45% (p < 0.01), and between the
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"process-ready" and "past-process" samples there was a 8% decrease (p < 0.05) (Figure 29).
The result indicates that post-harvest ripening has an impact on the actinidin activity and that
"process-ready" fruit is at an appropriate ripeness to pulp for a high actinidin content.
However the 45% increase between "pre-process" and "process-ready" samples was much
higher than reported values after kiwifruits were ripened, post-harvest with ethylene (Stewart
Boyes et al., 1997). This may mean that ethylene ripening does not increase the actinidin
activity as much as natural ripening that is conducted at the Kiwifruit Processing Company
Ltd.
Figure 29: Actinidin activity in fruit at the different processing stages at the processing plant. Four fruit at each
stage were homogenised together and assays were conducted in duplicates. Standard deviation of the mean is
shown as error bars.
4.2.4 Freeze drying
Pulp freezing
Kiwifruit pulp is blast frozen and stored at -20oC before it is transported to Christchurch and
freeze dried at Genesis Bio-Labs. Kiwifruit pulp from fresh fruit and pulp that had been
frozen and frozen pulp ready to be freeze dried was measured for actinidin activity to
measure the difference between the samples. A significant 46% loss (p < 0.01) of average
total activity for 100 mg of dry kiwifruit weight between the kiwifruit pulp  and frozen pulp
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was determined (Figure 30 (a)). This shows that kiwifruit pulping, freezing, and/or
transportation to Christchurch is having a negative impact on the retention of actinidin during
the production of Actazin™.
The activity drop appeared to correlate well with a highly significant drop (p < 0.01) in total
soluble protein content, also in 100 mg of kiwifruit dry weight (Figure 30 (b)). This indicates
that actinidin is becoming structurally denatured rather than catalytically inactivated. Proteins
are known to be sensitive to being frozen and thawed (Arakawa et al., 2001) and actinidin has
shown to lose 22% of its activity after it was purified from GrK, frozen and stored at -80oC
for 2 months before being thawed and assayed, as described in Chapter 2. It is therefore
recommended that the pulp is assayed for actinidin activity before and after it is frozen to
determine if the freezing, storage, or transportation is responsible for the loss of activity.
Figure 30: Process loss summary of actinidin in 100 mg of kiwifruit dry weight depicting the (a) total activity
and (b) total soluble protein content. Measurements were conducted from various samples including six fresh
fruit ("fresh fruit") and  at four locations on the frozen pulp ("frozen") and resulting freeze dried powder
("powder"). Standard deviation between these samples is shown as error bars.
Pulp drying
Freeze drying is a major transformation step during the processing of kiwifruit to Actazin™
powder. Frozen pulp is dried by applying a thermal gradient from below and around the trays
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that contain the pulp. The moisture is removed by sublimation, under vacuum as the
temperature is raised until the pulp becomes a powder. The temperature increase was
measured to understand whether the drying stage could affect the stability of actinidin.
Temperature data loggers were placed in the frozen pulp, which was then dried with the
temperature recorded at 5 minute intervals (Figure 31). From an initial starting temperature of
the frozen pulp at ***** the temperature increased during the drying stages to a maximal
temperature of **** before reducing to an ambient temperature of approximately ****, after
the sample had been removed from the freeze drier. The temperature profiles for the
individual data loggers, that were spaced across the tray (Figure 31) were similar and shows
that the heat is evenly distributed throughout the freeze drier.
Protein structure and function relies on the intricate folding of the protein, which can be
disrupted by temperature. The stability of actinidin's structure with increasing temperature
was measured previously using differential scanning fluorimetry (DSF) and was shown to be
affected by pH (Figure 10). The melting temperature of actinidin was 51oC at pH 3.7, which
is a similar pH as what was measured for the kiwifruit pulp. This could imply that the thermal
stability of actinidin at pH 3.7 is lower than the maximal temperature of **** reached during
freeze drying. The activity of actinidin, as determined using a casein-based assay has also
been found to be temperature dependent with the activity decreasing when temperatures were
raised above 45oC (M. Ha et al., 2012).This indicates that the stability and activity of
actinidin may be affected by the increases in temperature such as experienced during the
drying stages of freeze drying.
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Figure 31: Temperature change during freeze drying, as measured by iButton temperature data loggers every 5
minutes. The different lines represent individual data loggers that were positioned across the tray of frozen
kiwifruit pulp.
The retention of actinidin activity after the freeze drying stage was measured to assess if this
process had an effect on the activity. Both the frozen pulp (after defrosting) and the powder
were weighed out to a calculated kiwifruit dry weight in 50 mM phosphate buffer, pH 6 at a
concentration of 100 mg/mL dry weight. The measurements showed that there was a small
drop in average total activity for 100 mg of kiwifruit dry weight (Figure 30 (a)) before and
after the freeze drying. The changes, however were not significant and this indicates that
despite the fact that some actinidin can be lost during freeze drying (Figure 30 (b)) the
majority of actinidin is not negatively affected by the increase in temperature that occurs
(Figure 31) or the transformation from a liquid to an anhydrous state.
The retention of activity results are surprising given that the thermal stability of actinidin was
previously determined to be 51oC at pH 3.7 as assessed by DSF (Figure 10) whereas the
freeze drying process exposed the dried pulp to temperatures of ******* for approximately
******* (Figure 31). It was anticipated that there would be a significant drop of enzymatic
activity during drying. These results indicate that either differential scanning fluorimetry does
not appropriately simulate the thermal stability of actinidin in an anhydrous state or that other
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components in the pulp can protect actinidin as the pulp becomes dehydrated. There have
been previous studies that have shown the importance of lyoprotectants, such as sucrose for
the retention of enzymatic activity, (Carpenter et al., 1987) and structure (Prestrelski et al.,
1993) during freeze drying. Sugars can stabilise proteins when their hydration shell is lost
during freeze drying by forming a hydrogen bond network which prevents conformational
changes from occurring when the protein is dried (Carpenter et al., 1989; Hedoux et al.,
2013). Green kiwifruit contains 9 g of total sugars per 100 g of fruit (USDA, 2011) and this
may provide similar stabilising capacity to the proteins as the frozen pulp is exposed to an
increase in temperature. Thermal stability studies that investigate how saccharides affect the
stability of actinidin will help to determine the mechanism of actinidin stabilisation during
the drying. Studies on the thermal denaturation and inactivation of actinidin in an anhydrous
environment would also be desirable as these have direct implications on shelf life of stored
proteins in a variety of contexts. However within the current studies the absence of a
significant drop in actinidin activity after drying eliminates the possibility that freeze drying
is having a detrimental effect on actinidin activity retention.
4.3 Conclusion
4.3.1 Pre-harvest factors on actinidin activity
Pre-harvest factors are diverse and make it difficult to assess individual factors that affect the
actinidin content in kiwifruit. Instead the accumulative effect of the factors was assessed by
assaying a selection of fruit that was a representative sample of the kiwifruit used in the
pulping process. The results presented in Figure 27 showed that pre-harvest factors do affect
actinidin activity, however the variance follows a normal distribution and the pulping will
average the activity to a median value, which makes it unlikely that pre-harvest factors are
influential factors on the actinidin activity between batches of kiwifruit pulp.
4.3.2 Post-harvest factors on actinidin activity
The retention of actinidin activity after a 4-5 month cool storage period was high at 73% and
most likely not a significant contributor to losses of actinidin. The large variance in the
samples that had been stored for the extended period was hypothesised to be from the
condition of the fruit after it had been transported from the Bay of Plenty to Christchurch for
the activity to be analysed and therefore further testing is recommended for a more accurate
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idea as to the effects that cool storage has on actinidin.
Kiwifruit ripening has previously been found to increase actinidin activity (S. Boyes et al.,
1997). This literature precedent was supported by the results in Figure 29 that showed 'unripe'
kiwifruit had a lower specific activity to 'ripe' kiwifruit. This encourages the use of ripening
that is already conducted at the Kiwifruit Processing Company Ltd before the kiwifruit is
pulped.
Between pulping and freeze drying the frozen pulp at Genesis Bio-Labs there was a
significant loss of actinidin. Actinidin has shown to be sensitive to freezing and thawing over
a period of 2 months and this might be the major contributor to the retention of actinidin
during the production of Actazin™, however further testing is required to understand whether
the freezing, thawing, or storage at low temperatures is having the biggest impact on the
protein structure of actinidin.
The freeze drying process did not significantly affect the actinidin activity or content. This
was a surprising result as the temperature reached during the drying exceeded the thermal
stability of actinidin measured at pH 3.7. This implies that actinidin is stable during the
transformation of the kiwifruit pulp to the powder even if the temperature is raised up to
****.
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5 Chapter Five : Kiwellin Purification and
Characterisation
5.1 Introduction
5.1.1 Isolating kiwellin from kiwifruit
Kiwellin, constitutes a major portion of the soluble proteins that are found in kiwifruit
(Ciardiello et al., 2009) and can be isolated successfully from Actinidia chinesis kiwifruit
cultivars. The protein was first isolated using a high salt extraction method, that involved
separating kiwellin from the insoluble kiwifruit tissue with a salt solution. This was followed
with both anion- and cation-exchange chromatography steps, which isolated kiwellin from
the other soluble proteins present in the fruit (Tamburrini et al., 2005). An amino acid
sequence analysis of the purified kiwellin from (Actinidia chinensis) revealed that the protein
contained 189 residues in its sequence and had a theoretical molecular weight of 19,968 Da
(Tamburrini et al., 2005). The experimental molecular weight of kiwellin, shown by SDS-
PAGE analysis results in protein migration of a 28 kDa or 20 kDa species depending on
whether the analysis is conducted in reducing or non-reducing conditions, respectively
(Tamburrini et al., 2005) . The discrepancy in the experimental molecular weight is likely to
be from the reducing agent disrupting disulfide bonds that may be occurring between the 14
cysteine residues found in kiwellin's primary sequence.
Several isoforms of kiwellin exist amongst the most widely grown kiwifruit species. A
published sequence of kiwellin (Tamburrini et al., 2005) was BLAST searched on an
Actinidia expressed sequence tag database (Crowhurst et al., 2008) and revealed the different
isoforms (Maddumage et al., 2013). The sequences each contained 189 amino acids, as well
as a predicted signal peptide at the N-terminus of 23 amino acids. The sequences of the
different isoforms of kiwellin showed close homology with  > 95% sequence identity when
the sequences were aligned (Maddumage et al., 2013).
The level of kiwellin in Actinidia species varies considerably and this variation may be
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connected to the interactions kiwellin has with actinidin. Cultivars, such as Zespri® Hort16a
(Actinidia chinensis) shows high levels of kiwellin and low levels of actinidin (Maddumage
et al., 2013). Other cultivars also show this inverse relationship. The popular green kiwifruit
Hayward cultivars (Actinidia delicosia) has a high abundance of actinidin and a low
abundance of kiwellin (Maddumage et al., 2013). This relationship is postulated to be a result
of the proteolytic activity that actinidin has been shown to have for kiwellin. Kiwellin can be
cleaved into two domains, termed KiTH and kissper, which are 16 and 4 kDa respectively
(Tuppo et al., 2008). It is unclear why kiwellin is cleaved into KiTH and kissper, however the
cleavage may be connected to the physiological function of kiwellin.
5.1.2 Structure and function
Despite kiwellin contributing a major portion of the soluble proteins found in kiwifruit
(Ciardiello et al., 2009) there is no known physiological function for kiwellin. A sequence
alignment between kiwellin (Tamburrini et al., 2005) and homologs from a diverse range of
plant species, that were identified from BLAST searching NCBI databases, indicates that
kiwellin shows close homology with other plant proteins (between 74-79%) and conservation
of a number of amino acids (Figure 32). The plant homologs also did not have a known
biological function and were the product of annotated genome sequencing. This could imply
that these proteins share a physiological function, however further investigation is required.
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Kiwellin     1 ------------------------------ISSCNGPCRDLNDCDGQLICIKGKCNDDPQ
Grape        1 MANLALLLASLC-LL--SNI-FSLPFLAFAISSCGGPCQTLNDCEGQLICVSGKCNDDPD
Mulberry     1 MARFAFLDVSLS-LI--FNILISQSLPSHAISSCYGSCRDLNDCEGQLICINGKCNDDTD
Orange       1 MGKPLVSLASLS-LLTFFCT-ISLPLYSNAISQCNGPCGTLDDCDGQLICINGKCNDDPD
Burclover    1 MARISNLIFLACIFL--FNI-INIPFLTNAISSCNGPCNTLNDCDGQLICINGKCNDDPD
Kiwellin    31 VGTHICRGTTHS-H---QPGGCKPSGTLTCRGKSYPTYDCSPPVTSSTPAKLTNNDFSEG
Grape       57 VGTHICQTPSPSPP---SGSNCQASGTLTCGGISYPTYRCSPRVTSSTPAKLTNNDFSEG
Mulberry    58 LGTRICRRTPA--P----GGGCKQYGTLTCDGNTYPTYRCSPPVTSSTQAKLTNNDFSEG
Orange      59 VGTHICKGGEG--G---GGGNCQPSGTLTCQGNSYPTYKCSPPVTSSTQARLTNNDFSEG
Burclover   58 IGTHICTNPSPSPPSGGGGGTCQSSGTLQCKKKSYPQYRCSPPVSSSTQASLTLNDFSEG
Kiwellin    87 GDDGGPSECDESYHNNNERIVALSTGWYNGGSRCGKMIRITASNGKSVSAKVVDECDSRH
Grape      114 GDGGGASECDEQYHSNSERIVALSTGWYNGGSRCGKMIRITAQNGRSVVAKVVDECDSMR
Mulberry   112 GDGGGPSECDDRYHSNSERIVALSTGWYDGGSRCGKMIRITA-NGRSVVAKVVDECDSMH
Orange     114 GDGGGPSECDGQYHDNSKPIAALSTGWYSGGSRCGKMIRITANNGRSVLAQVVDECDSMR
Burclover  118 GDGGGPSQCDEKYHDNSERVVALSTGWYNGGSRCGKMIRITARNGRSVTAKVVDQCDSVN
Kiwellin   147 GCDKEHAGQPPCRNNIVDGSNAVWSALGLDKNVGVVDITWSMA
Grape      174 GCDQEHAYQPPCKNNIVDGSDAVWSALGLDKDIGVVDVTWTMA
Mulberry   171 GCDAEHAGQPPCKNNIVDGSDAVWSALGLNKDLGVVDVTWSMA
Orange     174 GCDEEHAGQPPCDNNIVDGSDAVWSALGLDKEIGIVDVTWSMS
Burclover  178 GCDKEHAGQPPCHNNIVDGSVSVWNALGLNTDDGVVPVTWSMA
Figure 32: Sequence alignment of homologs for kiwellin from other plant species using T-Coffee alignment
software (Notredame et al., 2000; Tommaso et al., 2011). The species, in order of appearance were, kiwellin
(Actinidia chinesis), grape (Vitis vinifera), mulberry (Morus, notabilis), orange (Citrus sinensis), burclover
(Medicago truncatula). GenBank accession numbers: P84527.1, XP_002285296.1, EXC22900.1,
XP_006488056.1, XP_003638071.1, respectively.
The secondary structure of kiwellin, as determined by circular dichroism spectroscopy (CD)
indicates that there are mainly helical structures, characterised by a CD trace with two
minima around 222 and 206 nm (Bernardi et al., 2010). The intensity of the two troughs was
affected by pH and increases in acidic (pH 4.5) environments. While there is an absence of
further structural information available for kiwellin the tertiary structure of the kissper
domain  has been solved by NMR spectroscopy (Ciardiello et al., 2008). The resolved spectra
identifies two short β-strands as well as a helical stretch for the 39 amino acid sequence.
Three disulfide bonds connect different regions of the peptide together and contribute to the
overall fold. The tight folding and secondary structures that kissper exhibits may also be
present in the corresponding region of its precursor, kiwellin, however the peptide may
become re-folded after cleavage from kiwellin. This provides uncertainties as to the structure
that kiwellin holds in solution and encourages further investigation.
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5.1.3 Bioactivity
There has been no evidence that kiwellin has bioactive properties, however there has been
preliminary results indicating that the kissper domain would have a positive impact in the
gastrointestinal (GI) tract. Despite also not knowing a physiological function of kissper, the
structural and chemical properties of the peptide are hypothesised to influence ion flux in
intestinal cells and combat inflammatory responses, such as neutralising reactive oxygen
species.
Kissper has shown a pH-dependent and voltage-gated pore-forming activity in model
synthetic planar lipid membranes (Ciardiello et al., 2008). The pore size of the channel was
calculated to have a diameter in the range of 1.9 to 7.6 Å for KCl and the ion selectivity can
change from anion to neutral to cation depending on the nature of the salt solution (Meleleo
et al., 2012). It is hypothesised that multiple kissper subunits contribute to the channel and
that the pore forming activity might promote the adsorption of substances in the GI tract
(Meleleo et al., 2012).
Inflammation can be a chronic symptom of functional bowel disorders, which creates a desire
to find anti-inflammatory agents that can prevent this response (Lee et al., 2014). The
antioxidant and anti-inflammatory properties of kissper on in vitro models for intestinal cells
from healthy and diseased patients was investigated and it was shown that kissper efficiently
counteracted oxidative stress and inflammatory responses after the cell lines were induced to
show an inflammatory response (Ciacci et al., 2013). This could provide a possible
mechanism to the anti-inflammatory responses that have been shown previously for aqueous
kiwifruit extracts (Edmunds et al., 2011). However further investigation is warranted in light
of the inconsistencies of the anti-inflammatory effects that kiwifruit extracts show between in
vitro and in vivo models (Edmunds et al., 2012).
5.2 Results and discussion
5.2.1 Purification of kiwellin
Kiwellin was extracted from two cultivars of Actinidia chinensis (GoK), which were Zespri®
Hort16a and Zespri® SunGold. The change between the Hort16a and SunGold cultivars
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occurred because of the prevalence of the bacteria Pseudomonas syringae pv. actinidiae (Psa)
that devastated the Hort16a orchards (Kiwifruit-Vine-Health, 2014). Kiwellin was purified
using a high salt extraction method, as previously described (Tamburrini et al., 2005). The
soluble proteins were extracted from the cell wall of the kiwifruit tissue upon addition of a
high salt solution in an alkaline environment. Kiwellin was separated from the other proteins
in this extract by using ion exchange chromatography. The kiwellin isoforms separated from
the Hort16a cultivar was used for the static light scattering and small angle X-ray scattering
experiments while kiwellin from the SunGold cultivar was used for the remaining
experiments outlined in this thesis.
The kiwifruit extract solution containing kiwellin was loaded onto a HiLoad™ Q HP anion
exchange chromatography column (GE Healthcare) after it had been dialysed into 10 mM
Tris-HCl, pH 7.5 buffer. Proteins that did not bind to the positively charged resin passed out
of the column as the flowthrough. Bound proteins were displaced using a 0 to 0.5 M NaCl
gradient (Figure 33). Five protein peaks eluted during the salt gradient (Figure 33), showing
that there are multiple proteins from GoK that bind to an anion exchange chromatography
column. The two major peaks (peak 3 and 4) that both appeared to show the presence of
kiwellin upon SDS-PAGE analysis was pooled in order to characterise both isoforms of
kiwellin. Further work characterising the two isoforms of kiwellin, separated using anion
exchange chromatography was proposed, however time restraints did not allow for the
additional characterisation experiments and is recommended in future studies that aim to
characterise kiwellin from A. chinensis cultivars.
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Figure 33: Anion exchange chromatography using a 5 mL HiLoad™ Q HP anion exchange column (GE
Healthcare). Protein that bound to the column  was eluted by increasing the salt concentration to 0.5 M NaCl
over six column volumes.
A cation exchange chromatography was used to further separate the kiwellin isoforms from
the other kiwifruit proteins. The pooled fractions from the anion exchange step were
exchanged into 10 mM Na acetate buffer at pH 5 by using a desalting column. The solution
was then injected onto a HiLoad™ SP HP cation exchange column (GE Healthcare), which
had been pre-equilibrated into the same buffer. Elution was carried out using a salt gradient
from 0 to 0.5 M NaCl over 6 column volumes. At a NaCl concentration of around 310 mM
kiwellin eluted as a single peak (peak 1) (Figure 34). A small shoulder was present at the start
of peak 1, however the protein species was unable to be identified by SDS-PAGE analysis
(data not shown). From a starting mass of 100 g of kiwifruit flesh 2.5 mg of kiwellin was
purified using anion and cation exchange chromatography. This is lower than previous studies
that reported 4 mg of kiwellin was purified from an equivalent starting mass (Tamburrini et
al., 2005).
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Figure 34: Cation exchange chromatography step using a 5 mL HiLoad™ Q SP cation exchange
chromatography column (GE Healthcare). Protein that bound to the column  was eluted by increasing the salt
concentration to 0.5 M NaCl over six column volumes.
Size exclusion chromatography was used to assess if any aggregate was present in the
purified kiwellin sample. It was also used to buffer exchange the sample into a low salt
phosphate buffer in preparation of characterisation studies including: static light scattering,
analytical ultracentrifugation, and crystallography screening. The protein eluted from the
HiLoad™ 16/600 Superdex™ pg 200 size exclusion column (GE Healthcare) as a single peak
(peak 1) after approximately 92 mL (Figure 35). The chromatography trace showed that there
was no aggregate that eluted as a higher molecular weight species.
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Figure 35: Size exclusion chromatography using a 120 mL HiLoad™ 16/600 Superdex™ pg 200 gel filtration
column (GE Healthcare). Elution was performed at 0.5 mL/min using 50 mM sodium phosphate buffer, pH 6.
The purity of kiwellin was assessed throughout the purification by use of SDS-PAGE
analysis, as there is no current assay to identify the presence of kiwellin in solution. A protein
standard (Invitrogen) was added (lane 1) to correlate the protein migration during
electrophoresis with a known molecular weight marker. Both the crude (lane 2) and
supernatant (lane 3) samples showed prominent protein bands at 15, 16, and 26 kDa as well
as minor bands below and between these bands. The 26 kDa protein band, which bound to
both the anion (lane 5 and 6) and the cation (lane 8) exchange chromatography columns was
hypothesised to be kiwellin. It has been previously shown that when kiwellin migrates during
electrophoresis under reducing conditions the molecular weight is higher than its theoretical
mass (Tamburrini et al., 2005), which may be due to the presence of disulfide bonds. The
flowthrough of the anion exchange step removed a 22 kDa protein (lane 4) and the
flowthrough of the cation exchange removed the 15 and 16 kDa protein (lane 7) from the
purified sample. The eluted kiwellin peak from (Figure 34) (lane 8) contained two protein
bands that was the two kiwellin isoforms.
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Figure 36: SDS-PAGE of the purification steps used to purify kiwellin. The proteins were in reducing conditions
and between 5-10 µg of protein was present in each lane. From left to right 1: molecular marker, 2: crude, 3:
supernatant, 4: anion exchange flow through, 5: anion exchange peak 3, 6: anion exchange peak 4, 7: cation
exchange flow through, 8: cation exchange peak 1.
5.2.2 Mass spectrometry
Mass spectroscopy was used to measure the mass of kiwellin, purified using anion and cation
exchange chromatography. The deconvoluted spectrum showed that there were two major
peaks, representing the two kiwellin isoforms, which had molecular weights of 19,766.28 and
19,795.81 Da (Figure 37). The molecular weight values of these peaks differs from the
theoretical molecular weight of 19,967.9 Da (Tamburrini et al., 2005) by -201.62 and -172.09
Da, respectively. A mass difference of 202.08 Da is the mass of the two amino acids,
methionine and alanine, which is present at the C-terminus of kiwellin (Figure 32). This may
indicate that these residues are susceptible to becoming cleaved off in the kiwifruit. The
difference between the two major peaks identified in Figure 37 is -29.53 Da. The difference is
similar for substituting several amino acid with another (Table 6). The tryptophan to arginine
substitution is proposed to be the most likely of these substitutions due to the binding
differences observed during anion exchange chromatography (Figure 33). Sequencing the
two kiwellin isoforms will identify what amino acid differences exist and the identity these
isoforms share with other isoforms of kiwellin that are found in Actinidia species






Table 6: Potential amino acid substitutions that may occur in different isoforms of kiwellin.
Amino acid substitution Average mass (Da)
Trp -> Arg -30.02
Ser -> Gly -30.03
Thr -> Ala -30.03
Met -> Thr -30.09
Figure 37: Deconvoluted ESI-MS spectrum of purified kiwellin at a concentration of 1 mg/mL. Two major
peaks are present at 19766.28 and 19795.81 Da, respectively.
5.2.3 Thermal stability
The thermal stability of kiwellin over the pH range of 3.6-7.6 was measured using a thermal
shift assay. The assay was conducted using differential scanning fluorimetry (DSF), which
measures the fluorescence given from a dye (SYPRO® Orange) when it binds to residues that
become exposed as the protein unfolds with increasing temperature (Niesen et al., 2007). An
increase in fluorescence of SYPRO® Orange was observed as the temperature was increased














unfolded (Figure 38). Across the different conditions tested there was a shift in the melting
curves indicating that pH is having an effect on the thermal stability of kiwellin. The intensity
of the fluorescence was lower than the actinidin sample, which was tested over a similar pH
range (Figure 9). This is likely to be due to actinidin (Podivinsky et al., 1989) having a higher
grand average of hydrophobicity score than kiwellin (Tamburrini et al., 2005) of -0.206 and -
0.656, respectively as computed by ProtParam (Gasteiger et al., 2005).
Figure 38: Melting curve of kiwellin, present in different buffers (pH 3.6-7.6), which are represented by
different colours. An increase in the fluorescence of SYPRO® Orange as the samples were heated from 20oC to
100oC is indicative of kiwellin becoming unfolded.
The results show that pH does affect the thermal stability of kiwellin. A melting temperature
was derived from the inflection point of the melting curve in each condition (Figure 38) and
is plotted as a function of pH (Figure 39). From pH 3.6 (59.5oC) the temperature increases
until it reaches pH 5.6 and 6.6 where it plateaus at 78oC and 78.5oC, respectively before
decreasing  thereafter in a more basic solution of pH 7.6 (75.7oC). Compared to other plant
proteins (Gorinstein et al., 1996), kiwellin has a high melting temperature and the influence
that pH has on its melting temperature suggests that a network of hydrogen bonds and also
salt bridges may be present in the tertiary structure.
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Figure 39: Melting temperature of kiwellin present in different buffers as determined from the inflection point of
the DSF melting curve (Figure 38). Each condition was measured in triplicates and the standard deviation of the
mean is shown as error bars.
5.2.4 Circular dichroism spectroscopy
The presence of secondary structures in purified kiwellin was assessed using circular
dichroism (CD) spectroscopy. The sample was prepared for the analysis by diluting the
sample in water to a concentration of 0.08 mg/mL to ensure that there was a sufficient
amount of light that reached the detector. The spectra of kiwellin between 180 and 240 nm
showed a peak at 200 nm that transitioned into a trough at 210 nm (Figure 40). The CD
spectra for kiwellin appears to represent that of an unfolded protein rather than one with
defined secondary structures, such as α-helices and β-strands (Greenfield, 2006), which
would reduce the amount of hydrogen bonding between amino acids and have implications
on the stability and flexibility of kiwellin. This result contrasts the CD spectra of kiwellin,
which was purified using a similar protocol, that showed the presence of α-helices at pH 7.5
(Bernardi et al., 2010). To confirm the reproducibility of the results the experiment was
conducted again using another batch of purified kiwellin, however this also resulted in a
similar measurement to the one shown in Figure 40 (data not shown). Bovine serum albumin
(BSA) (Sigma), which has α-helical secondary structures (Bujacz, 2012) was tested as a
positive control under analogous conditions to kiwellin to identify any experimental errors.
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The BSA sample gave a trace that had a maxima at 195 nm and trough between 210 nm and
224 nm. This is more characteristic of a spectra from proteins containing α-helices, which
typically show a minima at 206 nm and 222 nm (Greenfield, 2006) and this confirms that
BSA has α-helical secondary structures.
Figure 40: Circular dichroism spectra for kiwellin (black) and BSA (red). Each sample was measured three
times before being averaged.
5.2.5 Static light scattering
The quaternary structure of kiwellin in solution was analysed using a system that couples
static light scattering with size exclusion chromatography. Kiwellin eluted from the column
as a single species, represented by a single peak in the RI trace at around 17.5 mL (Figure
41). The peak was calculated to have an average molecular weight of 24.7 kDa, which is
higher than the theoretical molecular weight of 20.0 kDa (Tamburrini et al., 2005), but is
consistent with kiwellin existing as a monomer in solution. The range of molecular weight
values varied from 27.0 to 23.4 kDa and this shows that the sample is reasonably
monodisperse.
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Figure 41: Light scattering of kiwellin after the purified protein was eluted from a size exclusion column
(Superdex™ 200 10/300, GE Healthcare) with 100 mM sodium phosphate buffer, pH 7.
5.2.6 Analytical ultracentrifugation
Another technique that was used to measure the quaternary structure of kiwellin was
analytical ultracentrifugation (AUC). The rate at which kiwellin moved through the solution
after a gravitational field was applied was measured by the absorbance at 285 nm. The data
was fitted to a sigmodial curve and this was used to calculate the standardised sedimentation
coefficient of 2.4 S (Figure 42, (a)). The fitted data represented the experimental data well as
shown by the  residuals being evenly spaced (Figure 42, (b)).
A c(M) distribution of molecular weights was modelled using the calculated frictional
coefficient (f/f0) of 1.2 and showed that at 0.5 mg/mL kiwellin sediments as a monodisperse
species (Figure 42, (c)). The integrated peak gave an average molecular weight of 18.8 kDa,
which is close to the theoretical molecular weight of the primary structure of 20.0 kDa
(Tamburrini et al., 2005). This indicates that kiwellin exists as a monomer in solution,
consistent with the result obtained using static light scattering (Figure 41). The kissper
domain of kiwellin can form voltage-gated channels in synthetic lipid membranes (Ciardiello
et al., 2008; Meleleo et al., 2012), and this is hypothesised to be a bioactive property of the
peptide. One theory as to how the 39 amino acid peptide is able to form the channels is by
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multiple monomeric subunits bonding together to enable kissper to span the width of the
membrane (Meleleo et al., 2012). The interface used to form  the higher oligomeric kissper
structure may also be present in kiwellin, the precursor protein, however the data in Figure 41
and Figure 42 indicates that kiwellin does not form a higher oligomeric structure and exists as
a monomer in solution.
Figure 42: Analytical ultracentrifugation of kiwellin at 0.5 mg/ml. (a) absorbance at 285 nm measured the
sedimentation of kiwellin along the radius of rotation. (b) residuals for the fitted data indicate that the noise is
normally distributed. (c) A c(M) modelled size distribution shows a monodisperse species corresponding to a
monomer.
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5.2.7 Small angle X-ray scattering
Small angle X-ray scattering (SAXS) is a technique that can be used to describe the size and
shape of a macromolecule and was used in order to further characterise kiwellin in solution.
The intensity of the scattered X-rays is plotted as a function of the radial angle after the
scatter pattern from the phosphate buffer had been subtracted (Figure 43 (a)). Using PRIMUS
software (Konarev et al., 2003) the scatter intensity plot was used to create a Guinier plot
(Figure 43 (b)), which is an indication of data quality. The linearity of the Guinier plot shows
that the sample does not contain aggregates and that the sample is homogenous. The size of
kiwellin was calculated from the Guinier plot and resulted in a radius of gyration of 2.57 +/-
0.2 nm. The Porod volume, which estimates the maximum dimensions and molecular mass of
the species (M. V. Petoukhov et al., 2003) was also calculated using PRIMUS (Konarev et
al., 2003) to give a molecular weight of 17.2 kDa. This further confirms that kiwellin is a
monomer in solution. A Kratky plot was also calculated using the scatter intensity data and is
another indication of data quality (Figure 43 (d)). The incomplete bell-shaped curve, followed
by a tail at increasing radial angles is characteristic of a partially unfolded, flexible protein
(Putnam et al., 2007). The lack of secondary structures in the purified kiwellin that was
shown using CD spectroscopy (Figure 40) may be contributing to the flexible nature of the
protein which is having detrimental effects to the efforts of crystallising kiwellin.
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Figure 43: Small angle X-ray scattering of kiwellin at 5.11 mg/mL in 50 mM phosphate buffer, pH 7. (a). Scatter
intensity plot at different angles. (b). Guinier plot calculated from the scatter intensity plot using PRIMUS
software (Konarev, 2003). (c). P(r) distrbution. (d). Kratky plot calculated from the scatter intensity
The shape of a protein provides important structural information and can be obtained by
creating a pair distribution function plot from the SAXS data. The P(r) plot (Figure 43 (c))
shows an asymmetrical curve that has a tail which trails down to a Dmax at approximately 70
Å. This is indicative of an elongated structure and an Ab initio 3D envelope model of the
SAXS data for kiwellin using GASBOR (Svergun, 1992) depicts this structure (Figure 44).
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Kiwellin can be proteolytically cleaved by actinidin (Tuppo et al., 2008) and it is
hypothesised that the physiological function of kiwellin lies with the cleavage products,
KiTH and kissper. The elongated structure and flexible nature that kiwellin has shown from
the SAXS data may increase the chance that the cleavage site is exposed to actinidin and
leads to kiwellin becoming cleaved, which supports this hypothesis.
Figure 44: Ab initio model of kiwellin using the small angle X-ray scattering data and computed by GASBOR
software (Svergun, 1992).
5.2.8 X-ray crystallography
Crystal trials were conducted to obtain a crystal structure of kiwellin to resolve the protein
atomic structure. The crystal trays were prepared using the sitting drop method with a protein
concentration of 9.4 mg/mL. Four crystal screens were selected, which were JSCG,
Morpheus, PAC, and Clear Screen 1 (Molecular Dimensions) and the crystal trays were
incubated at 20oC to allow crystal formation. At time intervals of two weeks, one month, and
two months the crystal trays were checked to identify any crystal formation by use of light
microscopy, however no crystal formation was identified. The flexible nature of kiwellin, that
was identified using small angle X-ray scattering (Figure 43) would hinder crystal formation
and could explain why the protein is difficult to crystallise. Future crystal screens that cover
an expanded range of conditions may help to identify more suitable conditions that




A purification protocol that was developed previously (Tamburrini et al., 2005) which utilised
anion and cation exchange chromatography was used to isolate kiwellin, present in Actinidia
chinensis cultivars. Two kiwellin isoforms were purified and from 100 g of starting kiwifruit
flesh 2.5 mg of protein was isolated. Mass spectroscopy analysis also showed that the two
isoforms both had a molecular weight below that of the theoretical value of kiwellin
(Tamburrini et al., 2005). A truncated C-terminus was hypothesised to be the reason behind
the difference between one isoform and the theoretical mass. An amino acid substitution of
tryptophan to arginine was suggested to be the difference between the two isoforms, however
more detailed investigation of their sequences is needed to elucidate whether this hypothesis
is correct or not.
5.3.2 Biophysical characterisation
A biophysical characterisation of kiwellin was carried out using a number of analytical
techniques in order to better characterise this physiologically novel kiwifruit protein. The
thermal stability of kiwellin was measured using differential scanning fluorimetry and was
found to be influenced by pH. The high melting point of kiwellin and susceptibility to pH
indicates that a network of hydrogen bonds and salt bridges maintains its structure. Kiwellin,
similar to kissper may also have disulfide bonds that increases the stability of the protein and
the changes in electrophoresis migration during SDS-PAGE analysis under reducing
conditions supports this. Its structure was, however not found to contain any defined
secondary structure, as determined by CD spectroscopy. This is in contrast to previous studies
that showed that kiwellin had α-helicies in both neutral and acidic conditions (Bernardi et al.,
2010). The lack of secondary structure would allow kiwellin to have a more dynamic
structure in solution and this is consistent with the high flexibility that was observed from the
Kratky plot after a small angle X-ray scattering (SAXS) experiment. Kiwellin was calculated
to have a monomer in solution by using the three different techniques of: static light
scattering (SLS), analytical ultracentrifugation (AUC), and small angle X-ray scattering
(SAXS), as summarised in Table 6.
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Table 7: Predicted molecular mass of kiwellin as calculated from different analytical techniques.
Technique: Theoretical
(Tamburrini et al., 2005)
SLS AUC SAXS
Predicted mass (kDa): 20.0 24.7 18.8 17.2
SAXS was utilised to understand the shape of kiwellin in solution and was found to have an
elongated structure that had high flexibility and a radius of gyration (Rg) of 2.57 nm. The
shape was depicted using an ab initio model and it was hypothesised that these attributes
could promote the proteolytic cleavage of kiwellin into KiTH and kissper, which may have a
physiological relevance. The high flexibility was also hypothesised to have contributed to the
reasons as to why kiwellin did not crystallise in the crystal trays, which prevented an atomic
resolution of kiwellin from being obtained.
80
6 Chapter Six : Conclusions
6.1 Kiwifruit and digestive health benefits
Kiwifruit, a major horticultural export of New Zealand is associated with a number of health
benefits (Singletary, 2012). The positive impacts that kiwifruit consumption have on digestive
health has been particularly well researched. An increase in both the digestion of food
proteins and the frequency of waste efflux are common results that have been measured
during animal and human clinical trials, which assessed the health effects of kiwifruit
consumption. (Chan et al., 2007; Chang et al., 2010; Rush et al., 2002; Rutherfurd et al.,
2011). The components of kiwifruit that are implicated in improved digestive health include:,
fibre, bulking (Mishra et al., 2012), and the bioactive proteins: actinidin (Kaur et al., 2010a,
2010b; Montoya et al., 2014) and kissper (Ciacci et al., 2013; Ciardiello et al., 2008). The
bioactive properties of these proteins are specific to kiwifruit and this has sparked interest
from biotechnology companies that produce kiwifruit products, such as Actazin™ to
investigate these proteins.
6.2 Project aims
The project has two aims. Firstly the processing that produces Actazin™ is potentially having
a negative impact on the retention of actinidin. Routine quality control testing by Anagenix
Ltd measured that the percentage of actinidin in individual production batches vary by up to
48%. The intention of this research is to determine what factors affect the actinidin activity
and to provide direction for any optimisation of the production. The second aim of the project
was to characterise both actinidin and kiwellin and enhance the scientific information that is
known about these kiwifruit proteins. Kiwellin in particular has not been well characterised
and the physiological function is not known despite having shown that it can be
proteolytically cleaved into two domains (Tuppo et al., 2008), one of which, kissper may
have bioactive properties that increase digestive health (Ciardiello et al., 2008).
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6.3 Actinidin
6.3.1 Purification and characterisation of actinidin
Actinidin was purified from GrK kiwifruit (Actinidia deliciosa cv. Hayward) using anion
exchange chromatography. From 100 g of starting kiwifruit flesh 17 mg of protein was
isolated. The purified sample is hypothesised to contain multiple isoforms of actinidin as
shown by the mass spectroscopy analysis, and actinidin may have become catalytically
inactivated, which would explain why the specific activity was lower than previous studies
(Boland et al., 1972).
Purified actinidin was monomeric in solution and its melting temperature and catalytic
activity was affected by pH. Actinidin was most thermostable at pH values between 5-7, and
catalytically active at approximately pH 6. The melting point of actinidin at pH 6.7 was
similar to the melting point of an inactive form of actinidin, which had been previously
measured (M. M. Grozdanovic et al., 2014). This is further evidence that the purified
actinidin may be partially inactivated.
6.3.2 Pre- and post-harvest factors that affect actinidin activity
The specific activity of individual kiwifruit (GrK) demonstrated that the variation was
normally distributed and would therefore not impact the actinidin activity in the batches of
pulp after the kiwifruit had been pulped.
Cool storage, that slows kiwifruit ripening, had a limited impact on the actinidin activity.
After an extended 4-5 months of cool storage 73% of the activity was retained, consistent
with previous studies (S. Boyes et al., 1997). The loss of activity could have also been
affected by the condition of fruit, which was bruised and assaying a greater number of
samples to confirm these results is suggested.
The fruit is ripened before it is pulped and this process was determined to be important for
increasing actinidin activity. The ripening process that kiwifruit at the Kiwifruit Processing
Company Ltd goes through was shown to appropriately ripen the fruit, resulting in high
actinidin activity in comparison to fruit that had not been ripened.
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Purified actinidin was found to be sensitive to freezing and thawing over a 2 month period of
cold storage. Similarly, freezing the pulp before it was stored at -20oC was a processing stage
that had a detrimental impact on the retention of actinidin throughout the production of
Actazin™. It is therefore suggested that further investigations are carried out as to whether
the individual freezing, thawing, or storage stages at low temperatures are destabilising
actinidin or whether it was a combination effect of these.
During freeze drying the frozen pulp recorded temperature of up to ****. The rise in
temperature, however, did not significantly affect the actinidin activity of Actazin™.
6.3.3 Inactivation of actinidin in Actazin™
Actinidin in the kiwifruit powder became inactivated after the powder was solubilised in
phosphate buffer. The inactivation did not occur in the purified actinidin and it was
hypothesised that an oxidant in the kiwifruit powder was oxidising the catalytically active
cysteine residue. The hypothesis was supported by showing that in the presence of a reducing
agent the inactivation can be largely reversible. To investigate the mechanism of this
inactivation the effects that vitamin C and dissolved oxygen had on purified actinidin were
measured. The testing showed that neither vitamin C or dissolved oxygen were responsible
for actinidin becoming inactivated in the kiwifruit powder. Investigating the sensitivity of
actinidin towards oxidative reaction would be of interest in future work. The understanding
that actinidin is inactivated in the kiwifruit powder is, however more relevant to the project as
this might affect the measurements obtained in the quality control tests that are performed
regularly by Anagenix Ltd.
6.3.4 Recommendations to optimise Actazin™ production
Actazin™ is a kiwifruit product that is sold as a digestive aid. The production of Actazin™
involves pulping kiwifruit and freeze drying the pulp to produce a kiwifruit powder. To retain
a high level of actinidin throughout production the following is recommended.
Select fruit at the start of the season to reduce time in cool storage
The extended cool storage resulted in a decrease of actinidin activity when compared to fruit
that had not been stored for as long. The extended cool storage may have destabilised
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actinidin and selecting fruit at the start of the season will minimise any detrimental effects.
Continue the post-harvest ripening at the Kiwifruit Processing Company Ltd
Actinidin activity has been shown to positively react to prior fruit ripening (S. Boyes et al.,
1997) and the results presented in section 5.2.3 supports this. The ripening that had been
conducted was appropriate to increase the activity to a high value and this was supported by
showing that an extended ripening period had a detrimental effect on the actinidin activity
Freeze dry kiwifruit pulp that had been stored for short periods
Actinidin was found to be sensitive to cold storage after freezing and thawing. While freezing
is an essential part of production it is unclear whether storing the frozen pulp in cold storage
is further destabilising actinidin. A minimal cold storage period is therefore recommended to
prevent the potential for greater loss of actinidin activity.
Perform quality control tests under reducing conditions
Actinidin, in the kiwifruit powder become inactivated over time, but largely in the first 10
minutes of being solubilised in a buffer. To prevent the inactivation that may cause variations
between quality control tests, the addition of a reducing agent to the assay, which has been
shown to reverse the majority of the inactivation, is recommended.
6.4 Kiwellin
6.4.1 Purification and characterisation of kiwellin
Kiwellin was purified from two Actinidia chinensis cultivars using a protocol previously
developed (Tamburrini et al., 2005), which utilised both anion and cation exchange
chromatography. From 100 g of starting kiwifruit flesh 2.5 mg of protein was obtained. The
mass spectrum indicated that two truncated isoforms had been purified, however amino acid
sequencing is required for any confirmation.
A number of analytical techniques were implemented to better understand the structure of
kiwellin. The kiwifruit protein had a high melting temperature, which was also affected by
pH. It was hypothesised that hydrogen bonds and salt bridges are contributing to the stability
of kiwellin and are becoming destabilised in different pH environments. Disulfide bonds are
also suspected to be occurring between the 14 cysteine residues that kiwellin has in its
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primary structure. This conclusion was based upon the effects that reducing conditions had on
the protein migration during SDS-PAGE analysis. These bonds are important to stabilise
kiwellin in solution, which was found to be a dynamic species that did not have the presence
of any defined secondary structure. Static light scattering, analytical ultracentrifugation, and
small angle X-ray scattering (SAXS) determined that kiwellin was monomeric in solution.
SAXS also showed that kiwellin was an elongated protein that had a radius of gyration (Rg)
of 2.57 nm. The Kratky plot indicated that kiwellin was highly flexible and this may have
contributed to the reason why kiwellin did not crystallise in the crystal trials that were set up.
The flexiblity may also increase the chance that the cleavage site for actinidin that has
previously been described (Tuppo et al., 2008) had become exposed. This would promote
proteolytic cleavage and increase the amount of kissper and KiTH in the cell which might be
physiologically important.
85
7 Chapter Seven : Experimental
7.1 Materials
7.1.1 Chemicals
Unless otherwise stated, chemicals were purchased from: BDH, Thermo Fisher Scientific,
Sigma-Aldrich, or Scharlau Chemie S.A. Milli-Q water was used for all buffers and was
purified using an Advance A10 Water Purification System (Millipore).
7.1.2 Fruit selection
For protein extraction (actinidin and kiwellin) and for actinidin activity measurements, fruit
was bought from a local supermarket. A qualitative firmness test determined whether the fruit
was of sufficient ripeness. The green kiwifruit species used for studying actinidin was
Actinidia delicosia cv. Hayward (GrK). Kiwellin was extracted from Actinidia chinensis
species (GoK). Initially the Actinidia chinensis species used was the cultivar, Zespri®
Hort16a, however with the increase of Pseudomonas syringae pv. actinidiae (Psa) prevalence
(Mazzaglia et al., 2012) this was replaced with the commercially new Gold3 cultivar, which
is commonly known as Zespri® SunGold.
Fruit that was used to measure the influence of post-harvest factors on the retention of
actinidin activity was kindly gifted by Grant Jeffrey from Kiwifruit Processing Company Ltd,
which is based at Newnham Park in the Bay of Plenty. Harvested fruit was processed at this
facility into a pulp, flash frozen and transported down to Christchurch to be freeze dried at
Genesis Bio-Laboratory Ltd, New Zealand (Figure 3). Both the frozen pulp and kiwifruit
powder was obtained from Genesis Bio-Lab with agreement from its Director, Stephen
Parsons.
The section of the kiwifruit used to measure actinidin activity was the outer pericarp (flesh)
without the presence of seeds. This has previously been shown to have the highest actinidin




The pH of large volume buffers (> 250 mL) was confirmed using a UB-10 pH/mV meter
from Denver Instrument after it was calibrated using pH 4, 7, and 10 pH standards (Thermo
Fisher). For solutions with small volumes (100 µL to 50 mL) drops were pipetted onto a
S2K712 pocket-sized pH meter (Ichiro Co) until a stable reading was given. The pH probe
was initially calibrated with pH 4 and 7 standards, also from Ichiro Co. For fast confirmation




Actinidin was extracted from the outer pericarp tissue (flesh) of GrK. The flesh was
homogenised in a 2:1 ratio of extraction buffer (Table 8) (mL) to fruit weight (g) for 30-60
seconds, in a fruit blender. The crude mixture was centrifuged for 10 minutes at 17,600 rcf at
4oC to remove insoluble material. The supernatant was then decanted through a miracloth
filter and further centrifuged for 20 minutes at 52,600 rcf.
Ammonium sulfate was added to precipitate the soluble protein out of solution. Solid
ammonium sulfate was ground down to a powder by using a mortar and pestle and added to
the solution until the concentration reached 80% of the solution (53.3 g/100 mL). The
solution was incubated on ice for approximately 1.5 hours to allow the precipitant to form.
The precipitant was centrifuged for 15 minutes at 17,600 rcf before the solution, which was
measured to have no actinidin activity was decanted out of the sample. The precipitant was
usually found to float at the top of the solution and this was hypothesised to be due to the
density of the solution.
The precipitate was resuspended in a minimal amount of extraction buffer (Table 8) (10-20
mL/ 100g of starting kiwifruit flesh). The resuspension was dialysed over night in 12,000-
14,000 MWCO tubing (Medicell International Ltd) at 4oC in dialysis buffer (Table 8) to
remove any residual salt, after which the sample was centrifuged for 20 minutes at 52,600 rcf.
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Finally the solution was pushed through a 0.45 µm, followed by, a 0.2 µm  Minisart® filter
(Sigma-Aldrich) with a syringe.
Table 8: Buffer composition used during protein extraction.
Solution Contents




Actinidin dialysis buffer 50 mM NaPO4
1 mM EDTA
pH 6.0
Protein purification by chromatography
Similar to previous studies (Boland et al., 1972) actinidin was isolated from other proteins,
present in GrK by anion exchange chromatography. The sample was injected onto a 5 mL
HiLoad™ Q HP column (GE Healthcare). Bound protein was eluted by increasing the
concentration of NaCl from 0 to 500 mM over 6 column volumes. The protein eluting from
the column was monitored by the absorbance measured at 280 nm and 1 mL fractions were
collected in a 96 well plate.
The fractions containing the highest amount of protein (> 1000 mAU), deemed by the
absorbance at 280 nm were pooled. The pooled fractions (6 mL) were snapped frozen using
liquid nitrogen and stored at -80oC in 250 µL aliquots. A 22% decrease in activity was
measured after one month of storage. This appeared to not be minimised by the addition of
10% glycerol.
For further purification and to assess if the protein had aggregated, actinidin was eluted down
a size exclusion column. Samples were eluted down a 120 mL HiLoad™ 16/600 Superdex™
200 pg column (GE Healthcare) with a low salt buffer (Table 9), which had also been used to
equilibrate the column. Protein elution was monitored by the absorbance at 280 nm and 1 mL
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fractions were collected in a 96 well plate.
Table 9: Buffer composition used during chromatography steps.
Solution Contents








Kiwellin was extracted from Actinidia chinensis using the salt extraction method as
developed previously (Tamburrini et al., 2005). The outer pericarp (flesh) was removed from
the outer skin, seeds, and core and mixed with water at a ratio of 2 parts water (mL) to 1 part
fruit (g). This mixture was homogenised for 30-60 seconds in a fruit blender. The resulting
crude sample was centrifuged for 15 minutes at 17,600 rcf at 4oC. The pellet was resuspended
in a basic salt solution and 1 M NaOH was added, drop-wise until the pH reached
approximately 8. The pellet was then homogenised again for 15-30 seconds before the sample
was centrifuged at 52,600 rcf for 20 minutes. The solution was filtered through a 0.45 µm
Minisart® filter (Sigma-Aldrich)  and dialysed in 12,000-14,000 MWCO tubing (Medicell
International Ltd) overnight against 10 mM Tris-HCl, pH 7.5 buffer.
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Table 10: Buffer composition used during protein extraction.
Solution Contents
Kiwellin salt solution 0.5 M NaCl
Adjusted to pH 8.3 with 500 mM NaOH
Kiwellin dialysis buffer 10 mM Tris-HCl
Adjusted to pH 7.5 with 5 M NaOH
Protein purification by chromatography
The second step to isolate kiwellin from the other protein constituents was using anion
exchange chromatography, in accordance with a previously designed protocol (Tamburrini et
al., 2005). The protein sample that had been extracted from kiwifruit and dialysed was
injected onto a 5 mL HiLoad™ Q HP column, which had been equilibrated in low salt buffer
(Table 11). The bound protein was eluted by a linear gradient of high salt buffer from 0 to
100% over 6 column volumes. Any protein fractions that appeared to contain kiwellin, as
shown by SDS-PAGE analysis were pooled for further purification.
Cation exchange chromatography was utilised in the next chromatography step. Buffer
exchange into the cation exchange, low salt buffer was conducted by eluting the sample
through a 53 mL HiPrep™ 26/10 (GE Healthcare) desalting column that had been
equilibrated with the desired buffer. The protein sample was then injected onto a 1 mL
HiLoad™ SP HP column (GE Healthcare). Any protein that had bound to the column was
eluted by increasing the concentration of the high salt buffer (Table 11) from 0 to 100% over
6 column volumes. Protein fractions (> 800 mAU) corresponding to the highest absorbance at
280 nm were pooled. The purity of the purification throughout the chromatography steps was
checked by using SDS-PAGE analysis.
To assess aggregation and to exchange the buffer into a low salt phosphate buffer (Table 11)
the pooled sample was eluted through a size exclusion column. The sample was eluted down
a 120 mL HiLoad™ 16/600 Superdex™ 200 pg column (GE Healthcare) that had been
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equilibrated in low salt phosphate buffer at a flow rate of 1 mL/min. Fractions containing the
highest protein concentration, as determined by the absorbance at 280 nm were pooled and
concentrated using spin concentrators with a 10,000 MWCO (GE Healthcare).
Table 11: Buffer composition used during chromatography steps.
Solution Contents and Instructions
Anion exchange chromatography
Kiwellin low salt buffer 10 mM Tris-HCl
Adjusted to pH 7.5 with 5 M NaOH
Kiwellin high salt buffer 10 mM Tris-HCl
0.5 M NaCl
Adjusted to pH 7.5 with 5 M NaOH
Cation exchange chromatography
Kiwellin low salt buffer 10 mM Na acetate
Adjusted to pH 5.0 with conc HCl
Kiwellin high salt buffer 10 mM Na acetate
0.5 M NaCl
Adjusted to pH 5.0 with conc HCl
Size exclusion chromatography




Protein concentration was measured using the Bradford protein assay (Bradford, 1976)
throughout the purification and was used to calculate the specific and total activities of
actindin from fresh fruit, pulp, and freeze dried powder samples. The stain that was used was
the Protein Assay Dye Reagent Concentrate (Bio-Rad), which is a Coomassie Brilliant Blue
G-250 stain. Samples were prepared using either the microassay or microtiter plate protocols
(Bio-Rad).  The microassay procedure used 200 µL of a protein sample and this was added to
800 µL of protein stain, which had not been diluted. The samples were incubated for 10
minutes before the absorbance at 595 nm was measured using a spectrophotometer.
Absorbance measurements from 5 dilutions of BSA (Life Technologies) between 2 and 10
µg/mL was used to create a protein standard curve. The microtiter plate procedure used 15 µL
of protein sample and 185 µL of protein stain, that had previously been diluted 4 fold. The
absorbance at 595 nm was measured on a SpectraMax M5 plate reader after incubation for 10
minutes. The BSA standard curve was created from 10 dilutions over a range of 1 to 15 µg.
The protein concentration of purified protein samples was also measured by the absorbance at
280 nm using a NanoDrop ND 1000 spectrophotometer from Thermo Scientific after
blanking with the appropriate buffer. The concentrations were corrected using the calculated
extinction coefficients of actinidin (ACT1A) (Nieuwenhuizen et al., 2007), and kiwellin
(Tamburrini et al., 2005) which were 54235 and 23335 M-1 cm-1, respectively.
7.4 Protein SDS-PAGE
Protein gel electrophoresis was carried out using Bolt® Bis-Tris Plus precast polyacrylamide
gels (Invitrogen). Samples were prepared by adding 1 µL of NuPAGE® Sample Reducing
Agent (10X) (Invitrogen), 2.5 µL of NuPAGE® LDS Sample Buffer (4X) (Invitrogen), and a
suitable amount of protein sample to ensure each lane contained 5-10 µg of protein (typically
5 µL). Water was used to make a final loading volume of 10 µL. The samples were heated in
water to above 70 oC for 5 minutes before being loaded onto the precast gels. 5 µL of Novex®
Sharp Pre-Stained Protein Standard (Invitrogen) was pipetted into a lane, which was used as a
molecular weight ladder. The gels were run for 35 minutes at a constant voltage of 165 V in
1X NuPAGE® MES SDS Running Buffer. Gels were stained for 30 minutes with a
Coomassie stain and destained for approximately one hour. Protein bands were visualised and
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photographed using a Syngene Bio Imaging System.
Table 12: Staining and destaining solutions used show protein bands after electrophoresis.
Solution Contents
Coomassie stain (per 1 L) 1 g Coomassie Brilliant Blue G250
500 mL water
400 mL methanol
100 mL acetic acid
Destain (per 1 L) 500 mL water
400 mL methanol
100 mL acetic acid
7.5 Mass spectroscopy
Samples were prepared for mass spectrometry by dialysing the purified protein into water at a
protein concentration of approximately 1 mg/mL. 50 µL was pipetted into mass spectrometry
vials before being analysed on a maXis 3G UHR-Qq-TOF mass spectrometer
(BrukerDaltonik GmbH, Bremen, Germany) coupled to a Dionex Ultimate 3000 LC system
(ThermoFisher) with the expertise of Dr Marie Squire. 5 µL was injected from the sample
onto a Zorbax, 300Extend C8 Narrow Bore column at a flow rate of 200 µL/min. This was
followed by a ESI-L Low Concentration Tuning Mix (Agilent Technologies) as a calibrant.
Samples were eluted by running a gradient of acetonitrile (Scharlau, Multisolvent®, HPLC
grade) from 0-50% with water (purified using a MilliQ deionising system) and 0.5% formic
acid over 1 minute, followed by an isocratic hold on 50% for 1 minute and then a restoration
to 0% over 30 seconds. The method was finished with an isocratic hold on 0% acetonitrile
over 4.5 minutes. Mass spectrometer analysis was processed using Compass software
(BrukerDaltonik GmbH, Bremen, Germany).
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7.6 Temperature data loggers
iButton® temperature data loggers (Maxim Integrated, CA, U.S) supplied by FF
Instrumentation Ltd (Christchurch) were placed in a shallow groove cut into frozen kiwifruit
pulp just before freeze drying commenced. The frozen pulp was typically cut as slabs at a
thickness of 1 cm and the shallow groove was dug to approximately half of this thickness.
The four data loggers were distributed evenly across the tray. The tray was placed in the
middle of the freeze dryer. Changes in temperature were measured at time intervals of 5
minutes and data was analysed using 1-Wire Net software.
7.7 Differential scanning fluorimetry (DSF)
The thermal stability of actinidin and kiwellin was measured in different buffers by
differential scanning fluorimetry (DSF) (Niesen et al., 2007). For each condition a 100 µL
stock solution was made up containing: purified protein at either 0.1 mg/mL (actinidin) or 0.5
mg/mL (kiwellin), 1000 fold dilution of SYPRO® Orange (Sigma), and an appropriate
amount of buffer to increase the volume to 100 µL. The buffers used for the pH range tested
are listed below in Table 13. 25 µL of the stock solution were added to each well and each
condition was run as triplicates. The thermal melt was conducted by increasing the
temperature to 100oC at increments of 0.5oC per minute from 0oC using an iQ™5 Real-Time
PCR Detection System (Bio-Rad). Data was analysed using the iQ™5 software after the run
had been completed.
Table 13: Buffers selected to assess the thermal stability of actinidin and kiwellin using DSF.
Buffer Contents pH range
Citric 0.1 M Sodium citrate
0.1 M HCl
1.9-3
Citric-phosphate 0.1 M Citric acid
0.2 M Na2HPO4
3.6-7.6




7.8 Circular dichroism spectroscopy (CD)
Protein secondary structure was determined by UV circular dichroism spectroscopy (CD)
(Greenfield, 2006). Purified protein samples were pipetted into a quartz cuvette, with a cell
length of 0.2 cm. To ensure that there was a sufficient amount of light that reached the
detector the protein samples were diluted in water until a final  protein concentration in the
cuvette concentration was 0.08 mg/mL. The cuvette was placed in a JASCO J-815 CD
Spectrometer, purged with N2 gas. A continuous scan from 240 nm to 190 nm was run at a
scanning speed of 100 nm/min. Three scans were run for each sample and averaged. The
analysis was run using Spectra Manager J-800 Control Driver software (JASCO
Corporation). A final spectrum was obtained by subtracting the sample spectrum with the
averaged blank spectrum using CCAplus CD Analyser System.
7.9 Size-exclusion chromatography with in-line light scattering
(SEC/SLS)
Static light scattering was conducted using a Viscotek 302-040 Triple Detector GPC/SEC
system (ATA Scientific), operated at 30oC. 130 µL of the protein sample was injected onto a
24 mL Superdex™ 200 10/300 gel filtration column (GE Healthcare). The column had been
equilibrated in phosphate buffer (50 mM NaPO4, 1 mM EDTA, pH 6). Protein was eluted
from the column at a flow rate of 0.5 mL/min. Absolute molecular weight, radius of hydration
and size distributions was calculated using the refractive index (RI), intrinsic viscosity, and
right-angle light scattering (RALS) measurements as the eluted samples passed through the
detectors. Measurements were calibrated against a bovine serum albumin (BSA) standard
(66.5 kDa, Sigma), which was run at the beginning and end of each sample run. Calibration
was carried out using the OmniSEC software as per the manufacturer's instructions.
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7.10 Analytical Ultracentrifugation (AUC)
7.10.1 AUC measurements
Sedimentation velocity experiments were used to determined the size distribution of the
protein samples. The protein samples that were measured had previously been eluted down a
120 mL HiLoad™ 16/600 Superdex™ pg 200 size exclusion column (GE Healthcare),
equilibrated in 50 mM phosphate buffer at pH 6.0. 380 µL of the protein sample along with
400 µL of the phosphate buffer as a reference was used for the experiments. The protein
concentration was 0.5 mg/mL and 0.3 mg/mL for kiwellin and actinidin, respectively. The
samples were loaded into 12 mm double-sector cells with quartz windows in an eight hole
(An-50) rotor. The proteins were centrifuged at 201,600 rcf for 200 scans. UV/Vis scanning
optics that were attached to the Beckman Coulter Model XL-I analytical ultracentrifuge was
used to monitor the sedimentation of proteins at 285 nm. The experiment was conducted at
20oC under the supervision of Dr Grant Pearce.
7.10.2 AUC data analysis
Parameters such as: buffer density (1.0027 g/mL), buffer viscosity (0.01029 cp), and the
partial specific volume of actinidin (0.7232 mL/g) and kiwellin (0.70734 mL/g) were
computed using SEDNTERP (Laue, 1992) and used to analyse the data by the c(M) modelled
distribution in SEDFIT (Schuck, 2000).
7.11 Small angle X-ray scattering (SAXS)
7.11.1 SAXS measurements
Purified kiwellin was eluted down a 120 mL HiLoad™ 16/600 Superdex™ 200 pg size
exclusion column (GE Healthcare) in preparation for the analysis. The low salt phosphate
buffer that was used to equilibrate the column was also used to subtract the background
scatter. The protein sample, at 5.11 mg/mL was further eluted down an in-line 3 mL Superdex
200 5/150 gel filtration column (GE Healthcare), to remove any aggregated protein
immediately prior to data collection. SAXS measurements were performed at the Australian
Synchrotron SAXS/WAXS beamline equipped with a Pilatus 1M detector (170 mm X 170
mm, effective pixel size, 172 X 172 µm) by Dr Grant Pearce. The wavelength of the X-rays
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was 1.0332 Å. The sample-detector distance was 1600 mm, which provide a q range of
0.006-0.400 Å-1. Data was collected using a 1.5 mm glass capillary at 20oC under a
continuous flow in 2 second intervals. 2D intensity plots were radially averaged, normalised
to sample transmission, and background-subtracted.
7.11.2 SAXS data analysis
The 2D scattering plots were averaged and background scattering subtracted using
Scatterbrain software (Maxim V. Petoukhov et al., 2007). The scatter intensity plot, Guinier
plot, Porod volume, and Kratky plot were generated using PRIMUS (Konarev et al., 2003).
Indirect Fourier transform was performed using GNOM (Svergun, 1992) to yield the real-
space function P(r), which gives both the relative probabilities of distances between
scattering centres and the maximum dimension of the scattering particle, Dmax. GASBOR
(Svergun, 1992) was used for ab initio reconstruction of a 3D envelope model using the
SAXS data.
7.12 Crystallography screening
Crystal trays using the sitting drop method were laid down by use of a mosquito® Crystal
automated liquid distributer (TTP Labtech) in an attempt to crystallise kiwellin. 300 nL of
purified kiwellin at a concentration of 9.4 mg/mL (Abs280 nm) was added drop-wise to each
condition. From a 40 µL stock solution of each crystal screen condition 300 nL was taken and
added to the protein droplet. The screening conditions chosen were: JSCG, Morpheus, PAC,
and Clear Screen 1 (Molecular Dimensions). The 96 well plates were covered and incubated
at 20oC. At time intervals of two weeks, one month, and two months the crystal trays were
checked to identify any crystal formation by use of light microscopy.
7.13 Actinidin activity kinetics
7.13.1 General methods
The assay used for the kinetic analysis of actinidin has been used extensively in previous
studies (Baker et al., 1980; Boland et al., 1972) and was chosen as it gave fast and replicable
results. The reagents used in each assay and their respective concentrations are shown in
Table 14. Both the reagents, N-α-carbobenzoxy-L-lysine-p-nitrophenyl ester (CBZ-Lys-ONP)
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and cysteine were prepare using water as fresh solutions each time an activity assay
experiment was conducted and were stored on ice. The protein sample, containing actinidin
was also stored on ice throughout the assays, unless otherwise stated. Buffer was added to the
cuvette until a final volume of 1 mL was reached. The buffer used for all assays was a
phosphate buffer (100 mM NaPO4, 1 mM EDTA, pH 6), however during actinidin
purification the strength of phosphate was reduced to 50 mM. Neither buffer showed a strong
blank rate when CBZ-Lys-ONP was assayed with buffer alone and was pre-incubated at room
temperature before it was added to the cuvette. The addition of cysteine to the assay did,
however show a concentration dependent degradation of the substrate. A blank rate
containing cysteine, buffer, and CBZ-Lys-ONP was subtracted from all activity rates that
contained these reagents.
Table 14: Summary of reagents used for most assays and the concentration that were present in the 1 mL assay.
Reagent Stock solution Volume added Final cuvette concentration
Enzyme Variable 25 or 50 µL Variable
CBZ-Lys-ONP 8 mM 25 µL 200 µM
Cysteine 100 mM 50 µL 5 mM
Phosphate buffer 100 mM NaPO4
1 mM EDTA
pH 6
875/900 µL 100 mM NaPO4
1 mM EDTA
pH 6
The assays were run for 1.5 minutes at 25oC using a Cary 100 Bio UV-Visible
Spectrophotometer (Agilient Technologies). The absorbance change at 348 nm was recorded
after the reaction was initiated by the addition of CBZ-Lys-ONP. The reaction rate was
measured by calculating the gradient of the linear portion of the slope at the start of the
reaction, which was between the time points of 10-50 seconds. Assays were run in either
duplicates or triplicates.
7.13.2 Kinetic analysis of fresh fruit
The actinidin activity from the fresh fruit obtained from Kiwifruit Processing Company Ltd
and the fruit used to measure activity variations between individual fruits was processed and
assayed using an analogous method. The fruit was deskinned, deseeded, and the core was
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removed, which left the outer pericarp tissue (flesh). The flesh was homogenised for 30-60
seconds in a 2:1 ratio of phosphate buffer (100 mM, pH 6) (mL) and flesh (g). The sample
was centrifuged at 10,000 rcf for 10 minutes at 4oC. The supernatant was decanted from the
insoluble material and diluted 4 fold. Either 25 or 50 µL of the kiwifruit sample was used for
the assays. 5 mM of cysteine was added to the cuvette to prevent any inactivation from
occurring. A blank rate of 5 mM cysteine and CBZ-Lys-ONP was measured and subtracted
from the activity rate.
7.13.3 Kinetic analysis of samples before and after lyophilisation
To determine whether freeze drying was affecting the retention of actinidin the activity
difference between the frozen pulp and freeze dried kiwifruit powder was measured. Pulp and
powder samples (4) were taken within the same region as their respective temperature data
logger, which was used to measure the temperature throughout the transformation.
Both the pulp (after being defrosted) and kiwifruit powder from Genesis Bio-Lab was
weighed out to a kiwifruit dry weight concentration of 100 mg/ml. The water content of
kiwifruit at 85% was taken into consideration when calculating the weight needed for the
desired concentration of dry weight in the pulp sample. Phosphate buffer (100 mM, pH 6)
was added to the sample to obtain the concentration. The samples were then centrifuged at
14,000 rcf for 5 minutes at room temperature before the supernatant was diluted 5 fold and
assayed. The assay cuvette contained 5 mM cysteine to prevent inactivation and the blank
rate was correctly accounted for.
7.13.4 Michaelis-Menten kinetics
Kinetic parameters for the activity assay were calculated from the relationship between
enzymatic activity and substrate concentration. The substrate concentration was increased by
pipetting a larger volume of substrate from a 8 mM stock solution. 16 concentrations of the
substrate were measured that ranged from 7 µM to 720 µM. The enzyme concentration
remained constant for each assay by adding 50 µL of a purified actinidin stock solution of
0.034 mg/mL (Abs280 nm) to each cuvette. This gave a final cuvette concentration of 0.072
µM.
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7.13.5 Effect that pH on activity rates
The effect that pH had on the activity was assessed using buffer solutions with a pH range of
2-9. The buffers that were used was either citric, citric-phosphate, or a tris-base buffer (Table
13). A blank rate of buffer and CBZ-Lys-ONP was measured for each pH condition. This rate
was subtracted from the activity rate measured in the presence of actinidin before specific
activity was calculated. 50 µL of actinidin from a stock solution of 0.12 mg/mL (Abs280 nm)
was added to the cuvette, which gave a final cuvette concentration of 0.25 µM.
7.13.6 Time dependent inactivation
The time dependent inactivation measured any loss of actinidin kinetic activity over 120
minutes after the kiwifruit sample was prepared. Freeze dried kiwifruit powder was
solubilised in phosphate buffer (100 mM, pH 6) at a concentration of 100 mg/mL. The
samples were then centrifuged at 9,700 rcf for 2 minutes at room temperature. The resulting
supernatant was diluted 5 fold and assayed immediately using 25 µL of this stock solution.
Assays were conducted every 5 minutes thereafter and samples were stored at room
temperature.
7.13.7 Effect of vitamin C on activity rates
A concentration range of vitamin C measured the effects that vitamin C had on activity rates.
From a 1 M stock solution of vitamin C varying volumes were pipetted into the cuvette to
obtain final concentrations of: 0, 1, 10, 20, 40, 60, 80 and 100 mM. The ascorbate dibasic
sodium salt was used as opposed to ascorbic acid due to the acidic pH change that occurred
when using ascorbic acid. 50 µL of purified actinidin from a stock solution of 0.042 mg/mL
(Abs280 nm) gave an assay concentration of 0.088 µM.
7.13.8 Effect of dissolved oxygen on activity rates
Dissolved oxygen present in the buffer was measured to understand whether this could have
an impact on actinidin activity. A YSI550A portable dissolved oxygen probe (YSI) was used
to measure the dissolved oxygen present in the phosphate buffer before and after it was
degassed. The buffer, that was added to the cuvette to make a final volume 1 mL was
degassed under a vacuum while a stirring bar was used to release the oxygen for
approximately one hour. Oxygen was further released from the buffer by placing the buffer in
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a sonicating bath for 5 minutes (not under vacuum). Assays were conducted immediately
after 50 µL of purified actinidin was added to the cuvette or after the cuvette, which
contained the enzyme was incubated at room temperature for one hour. The cuvette that was
incubated either did or did not contain vitamin C at a concentration of 20 mM. The enzyme
stock solution concentration was 0.042 mg/mL (Abs280 nm), which gave an assay
concentration of 0.088 µM.
7.13.9 Activation of actinidin using reducing agents
The inactivation of actinidin in the powder was reversed by incubating samples in the
presence of a reducing agent, prior to the sample being assayed. Dithiothreitol (DTT),
cysteine, and β-mercaptoethanol  were added to an assay containing kiwifruit powder that
was being measured over a period of 120 minutes. The final cuvette concentration for each
reducing agent was 5 mM and this was achieved by pipetting 50 µL of the appropriate
reducing agent into the cuvette from a 100 mM stock solution. The activity of actinidin
present in kiwifruit powder (100 mg/mL) was measured every 30 minutes as a control. After
the control sample was measured for its drop in activity the assay was repeated in the
presence of the respective reducing agent after a 2 minute incubation period.
7.13.10 Concentration dependent activation of actinidin with cysteine
The concentration effects of cysteine on the activation of actinidin, present in the kiwifruit
powder was measured to observe any differences over a 30 hour time period. Cysteine was
pipetted into the kiwifruit powder sample (100 mg/mL) from a 100 mM stock solution to give
a final concentration of either: 1, 3, 5, 10, 20, 30, or 40 mM. The protective effect of cysteine
on actinidin activity was monitored by taking activity measurements at the time points of: 0,
5, 10, 20, 25, and 30 hours.
101
8 Chapter Eight : References
Arakawa, T., Prestrelski, S. J., Kenney, W. C., & Carpenter, J. F. (2001). Factors affecting
short-term and long-term stabilities of proteins. Advanced Drug Delivery Reviews,
46(1-3), 307-326.
Armstrong, D. A., & Buchanan, J. D. (1978). Reaction of O2-, H2O2 and other oxidants with
sulfhydryl enzymes. Photochemistry and Photobiology, 28(4-5), 743-755.
Baker, E. N. (1980). Structure of actinidin, after refinement at 1.7 A resolution. J Mol Biol,
141(4), 441-484.
Baker, E. N., Boland, M. J., Calder, P. C., & Hardman, M. J. (1980). The specificity of
actinidin and its relationship to the structure of the enzyme. Biochim Biophys Acta,
616(1), 30-34.
Bernardi, M. L., Picone, D., Tuppo, L., Giangrieco, I., Petrella, G., Palazzo, P., et al. (2010).
Physico-chemical features of the environment affect the protein conformation and the
immunoglobulin E reactivity of kiwellin (Act d 5). Clin Exp Allergy, 40(12), 1819-
1826.
Boland, M. J., & Hardman, M. J. (1972). Kinetic studies on the thiol protease from Actinidia
chinensis. FEBS Lett, 27(2), 282-284.
Bonvehi, J. S., Jorda, R. E., & Jaen, J. A. (1997). The ripening process of kiwifruits
(Actinidia deliciosa) grown in Catalonia, Spain. Journal of Food Quality, 20(5), 371-
380.
Boyes, S., Strubi, P., & Marsh, H. (1997). Actinidin levels in fruit of Actinidia species and
some Actinidia arguta rootstock scion combinations. Food Science and Technology-
Lebensmittel-Wissenschaft & Technologie, 30(4), 379-389.
Boyes, S., Strübi, P., & Marsh, H. (1997). Sugar and Organic Acid Analysis ofActinidia
argutaand Rootstock–Scion Combinations ofActinidia arguta. LWT - Food Science
and Technology, 30(4), 390-397.
Bradford, M. M. (1976). Rapid and sensitive method for quantitation of microgram quantities
of protein utilizing principle of protein-dye binding Analytical Biochemistry, 72(1-2),
248-254.
Brevik, A., Gaivao, I., Medin, T., Jorgenesen, A., Piasek, A., Elilasson, J., et al. (2011).
102
Supplementation of a western diet with golden kiwifruits (Actinidia chinensis
var.'Hort 16A':) effects on biomarkers of oxidation damage and antioxidant
protection. Nutr J, 10, 54.
Brocklehurst, K., Baines, B. S., & Malthouse, J. P. (1981). Differences in the interaction of
the catalytic groups of the active centres of actinidin and papain. Rapid purification of
fully active actinidin by covalent chromatography and characterization of its active
centre by use of two-protonic-state reactivity probes. Biochem J, 197(3), 739-746.
Brocklehurst, K., Willenbrock, F., & Salih, E. (1987). Chapter 2 Cysteine proteinases. In A.
Neuberger & K. Brocklehurst (Eds.), New Comprehensive Biochemistry (Vol. Volume
16, pp. 39-158).
Bujacz, A. (2012). Structures of bovine, equine and leporine serum albumin. Acta Crystallogr
D Biol Crystallogr, 68(Pt 10), 1278-1289.
Buttriss, J. L., & Stokes, C. S. (2008). Dietary fibre and health: an overview. Nutrition
Bulletin, 33(3), 186-200.
Carotti, A., Hansch, C., Mueller, M. M., & Blaney, J. M. (1984). Actinidin hydrolysis of
substituted-phenyl hippurates: a quantitative structure-activity relationship and
graphics comparison with hydrolysis by papain. J Med Chem, 27(11), 1401-1405.
Carpenter, J. F., & Crowe, J. H. (1989). An infrared spectroscopic study of the interactions of
carbohydrates with dried proteins. Biochemistry, 28(9), 3916-3922.
Carpenter, J. F., Crowe, L. M., & Crowe, J. H. (1987). Stabilization of phosphofructokinase
with sugars during freeze-drying-characterization of enhanced protection in the
presence of divalent-cations. Biochim Biophys Acta, 923(1), 109-115.
Cavic, M., Grozdanovic, M., Bajic, A., Srdic-Rajic, T., Andjus, P. R., & Gavrovic-Jankulovic,
M. (2012). Actinidin, a protease from kiwifruit, induces changes in morphology and
adhesion of T84 intestinal epithelial cells. Phytochemistry, 77, 46-52.
Chan, A. O. O., Leung, G., Tong, T., & Wong, N. Y. H. (2007). Increasing dietary fiber intake
in terms of kiwifruit improves constipation in Chinese patients. World Journal of
Gastroenterology, 13(35), 4771-4775.
Chang, C.-C., Lin, Y.-T., Lu, Y.-T., Liu, Y.-S., & Liu, J.-F. (2010). Kiwifruit improves bowel
function in patients with irritable bowel syndrome with constipation. Asia Pacific
Journal of Clinical Nutrition, 19(4), 451-457.
Ciacci, C., Russo, I., Bucci, C., Iovino, P., Pellegrini, L., Giangrieco, I., Tamburrini, M., &
Ciardiello, M. A. (2013). The Kiwifruit Peptide Kissper Displays Anti-Inflammatory
103
and Antioxidant Effects in In Vitro And Ex Vivo Human Intestinal Models. Clin Exp
Immunol.
Ciardiello, M. A., Giangrieco, I., Tuppo, L., Tamburrini, M., Buccheri, M., Palazzo, P.,
Bernardi, M. L., Ferrara, R., & Mari, A. (2009). Influence of the Natural Ripening
Stage, Cold Storage, and Ethylene Treatment on the Protein and IgE-Binding Profiles
of Green and Gold Kiwi Fruit Extracts. J Agric Food Chem, 57(4), 1565-1571.
Ciardiello, M. A., Meleleo, D., Saviano, G., Crescenzo, R., Carratore, V., Camardella, L., et
al. (2008). Kissper, a kiwi fruit peptide with channel-like activity: structural and
functional features. J Pept Sci, 14(6), 742-754.
Crowhurst, R. N., Gleave, A. P., MacRae, E. A., Ampomah-Dwamena, C., Atkinson, R. G.,
Beuning, L. L., et al. (2008). Analysis of expressed sequence tags from Actinidia:
Applications of a cross species EST database for gene discovery in the areas of flavor,
health, color and ripening. Bmc Genomics, 9.
Cruz-Castillo, J. G., Baldicchi, A., Frioni, T., Marocchi, F., Moscatello, S., Proietti, S.,
Battistelli, A., & Famiani, F. (2014). Pre-anthesis CPPU low dosage application
increases ‘Hayward’ kiwifruit weight without affecting the other qualitative and
nutritional characteristics. Food Chem, 158(0), 224-228.
D'Avino, R., Bernardi, M. L., Wallner, M., Palazzo, P., Camardella, L., Tuppo, L., et al.
(2011). Kiwifruit Act d 11 is the first member of the ripening-related protein family
identified as an allergen. Allergy, 66(7), 870-877.
Datson, P. M., & Ferguson, A. R. (2011). Actinidia. In C. Kole (Ed.), Wild Crop Relatives:
Genomic and Breeding Resources (pp. 1-20).
Drossman, D. A. (2006). The functional gastrointestinal disorders and the Rome III process.
Gastroenterology, 130(5), 1377-1390.
Du, G., Li, M., Ma, F., & Liang, D. (2009). Antioxidant capacity and the relationship with
polyphenol and Vitamin C in Actinidia fruits. Food Chem, 113(2), 557-562.
Edmunds, S. J., Roy, N. C., Davy, M., Cooney, J. M., Barnett, M. P. G., Zhu, S., Park, Z.,
Love, D. R., & Laing, W. A. (2012). Effects of kiwifruit extracts on colonic gene and
protein expression levels in IL-10 gene-deficient mice. British Journal of Nutrition,
108(1), 113-129.
Edmunds, S. J., Roy, N. C., Love, D. R., & Laing, W. A. (2011). Kiwifruit extracts inhibit
cytokine production by lipopolysaccharide-activated macrophages, and intestinal
epithelial cells isolated from IL10 gene deficient mice. Cellular Immunology, 270(1),
104
70-79.
Eshamah, H., Han, I., Naas, H., Acton, J., & Dawson, P. (2014). Antibacterial effects of
natural tenderizing enzymes on different strains of Escherichia coli O157:H7 and
Listeria monocytogenes on beef. Meat Sci(0).
FAOSTAT. (2012). Food and Agriculture Organization of the United Nations. (7 July 2014).
Retrieved from http://faostat3.fao.org/faostat-gateway/go/to/download/Q/QC/E
Ferguson, A. R. (2004). 1904 - the year that kiwifruit (Actinidia deliciosa) came to New
Zealand. New Zealand Journal of Crop and Horticultural Science, 32(1), 3-27.
Ferrandino, A., & Lovisolo, C. (2014). Abiotic stress effects on grapevine (Vitis vinifera L.):
Focus on abscisic acid-mediated consequences on secondary metabolism and berry
quality. Environmental and Experimental Botany, 103, 138-147.
Fiorentino, A., D'Abrosca, B., Pacifico, S., Mastellone, C., Scognamiglio, M., & Monaco, P.
(2009). Identification and Assessment of Antioxidant Capacity of Phytochemicals
from Kiwi Fruits. J Agric Food Chem, 57(10), 4148-4155.
Fukal, L., Kas, J., & Rauch, P. (1984). Inactivation of papain proteolytic activity in the
presence of ascorbic acid and Cu++ ions. Journal of the Institute of Brewing, 90(2),
73-76.
Gasteiger, E., Hoogland, C., Gattiker, A., Duvaud, S. e., Wilkins, M., Appel, R., & Bairoch,
A. (2005). Protein Identification and Analysis Tools on the ExPASy Server. In J.
Walker (Ed.), The Proteomics Protocols Handbook (pp. 571-607).
Gavrovic-Jankulovic, M., cIrkovic, T., Vuckovic, O., Atanaskovic-Markovic, M., Petersen,
A., Gojgic, G., Burazer, L., & Jankov, R. M. (2002). Isolation and biochemical
characterization of a thaumatin-like kiwi allergen. [Research Support, Non-U.S.
Gov't]. J Allergy Clin Immunol, 110(5), 805-810.
Gerasopoulos, D., & Drogoudi, P. D. (2005). Summer-pruning and preharvest calcium
chloride sprays affect storability and low temperature breakdown incidence in
kiwifruit. Postharvest Biology and Technology, 36(3), 303-308.
Gorinstein, S., Zemser, M., Friedman, M., Rodrigues, W. A., Martins, P. S., Vello, N. A.,
Tosello, G. A., & ParedesLopez, O. (1996). Physicochemical characterization of the
structural stability of some plant globulins. Food Chem, 56(2), 131-138.
Greenfield, N. J. (2006). Using circular dichroism spectra to estimate protein secondary
structure. Nature Protocols, 1(6), 2876-2890.
Grozdanovic, M., Popovic, M., Polovic, N., Burazer, L., Vuckovic, O., Atanaskovic-
105
Markovic, M., Lindner, B., Petersen, A., & Gavrovic-Jankulovic, M. (2012).
Evaluation of IgE reactivity of active and thermally inactivated actinidin, a biomarker
of kiwifruit allergy. [Research Support, Non-U.S. Gov't]. Food Chem Toxicol, 50(3-
4), 1013-1018.
Grozdanovic, M. M., Ostojic, S., Aleksic, I., Andjelkovic, U., Petersen, A., & Gavrovic-
Jankulovic, M. (2014). Active actinidin retains function upon gastro-intestinal
digestion and is more thermostable than the E-64-inhibited counterpart. J Sci Food
Agric.
Gudkov, S. V., Karp, O. E., Garmash, S. A., Ivanov, V. E., Chernikov, A. V., Manokhin, A. A.,
Astashev, M. E., Yaguzhinsky, L. S., & Bruskov, V. I. (2012). Generation of reactive
oxygen species in water under exposure to visible or infrared irradiation at absorption
bands of molecular oxygen. Biophysics, 57(1), 1-8.
Ha, M., Bekhit, A. E.-D., & Carne, A. (2014). Effects of L- and iso-ascorbic acid on meat
protein hydrolyzing activity of four commercial plant and three microbial protease
preparations. Food Chem, 149, 1-9.
Ha, M., Bekhit, A. E., Carne, A., & Hopkins, D. L. (2013). Characterisation of kiwifruit and
asparagus enzyme extracts, and their activities toward meat proteins. Food Chem,
136(2), 989-998.
Ha, M., Bekhit, A. E. A., Carne, A., & Hopkins, D. L. (2012). Characterisation of commercial
papain, bromelain, actinidin and zingibain protease preparations and their activities
toward meat proteins. Food Chem, 134(1), 95-105.
Hedoux, A., Paccou, L., Achir, S., & Guinet, Y. (2013). Mechanism of protein stabilization by
trehalose during freeze-drying analyzed by in situ micro-raman spectroscopy. Journal
of Pharmaceutical Sciences, 102(8), 2484-2494.
Kamphuis, I. G., Drenth, J., & Baker, E. N. (1985). Thiol proteases. Comparative studies
based on the high-resolution structures of papain and actinidin, and on amino acid
sequence information for cathepsins B and H, and stem bromelain. J Mol Biol, 182(2),
317-329.
Kamphuis, I. G., Kalk, K. H., Swarte, M. B. A., & Drenth, J. (1984). Structure of papain
refined at 1.65 Å resolution. J Mol Biol, 179(2), 233-256.
Kanazawa, H., Fujimoto, S., & Ohara, A. (1994). On the mechanism of inactivation of active
papain by ascorbic-acid in the presence of cupric ions. Biological & Pharmaceutical
Bulletin, 17(6), 789-793.
106
Karlsen, A., Svendsen, M., Seljeflot, I., Laake, P., Duttaroy, A. K., Drevon, C. A., Arnesen,
H., Tonstad, S., & Blomhoff, R. (2013). Kiwifruit decreases blood pressure and
whole-blood platelet aggregation in male smokers. Journal of Human Hypertension,
27(2), 126-130.
Katsaros, G. I., Tavantzis, G., & Taoukis, P. S. (2010). Production of novel dairy products
using actinidin and high pressure as enzyme activity regulator. Innovative Food
Science and Emerging Technologies, 11(1), 47-51.
Kaur, L., Rutherfurd, S. M., Moughan, P. J., Drummond, L., & Boland, M. J. (2010a).
Actinidin enhances gastric protein digestion as assessed using an in vitro gastric
digestion model. J Agric Food Chem, 58(8), 5068-5073.
Kaur, L., Rutherfurd, S. M., Moughan, P. J., Drummond, L., & Boland, M. J. (2010b).
Actinidin enhances protein digestion in the small intestine as assessed using an in
vitro digestion model. J Agric Food Chem, 58(8), 5074-5080.
Kitts, D. D., & Weiler, K. (2003). Bioactive proteins and peptides from food sources.
Applications of bioprocesses used in isolation and recovery. Current Pharmaceutical
Design, 9(16), 1309-1323.
Kiwifruit-Vine-Health. (2014). Kiwifruit Vine Health Psa Statistics. Retrieved from
http://www.kvh.org.nz/vdb/document/453
Ko, S. H., Choi, S. W., Ye, S. K., Cho, B. L., Kim, H. S., & Chung, M. H. (2005).
Comparison of the antioxidant activities of nine different fruits in human plasma.
Journal of Medicinal Food, 8(1), 41-46.
Konarev, P. V., Volkov, V. V., Sokolova, A. V., Koch, M. H. J., & Svergun, D. I. (2003).
PRIMUS: a Windows PC-based system for small-angle scattering data analysis.
Journal of Applied Crystallography, 36, 1277-1282.
Konno, K., Hirayama, C., Nakamura, M., Tateishi, K., Tamura, Y., Hattori, M., & Kohno, K.
(2004). Papain protects papaya trees from herbivorous insects: role of cysteine
proteases in latex. Plant Journal, 37(3), 370-378.
Laue, T. M. S., B.D. Ridgeway, T.M. Pelletier, S.L. (1992). Analyticall Ultracentrifugation in
Biochemistry and Polymer Science: Royal Society of Chemistry.
Lee, Y. J., & Park, K. S. (2014). Irritable bowel syndrome: Emerging paradigm in
pathophysiology. World Journal of Gastroenterology, 20(10), 2456-2469.
Lewis, D. A., & Luh, B. S. (1988). Development and distribution of actinidin in kiwifruit
(Actinidia-chinensis) and its partial characterization. Journal of Food Biochemistry,
107
12(2), 109-116.
Lin, W. S., Armstrong, D. A., & Gaucher, G. M. (1975). Formation and repair of papain
sulfenic acid. Canadian Journal of Biochemistry, 53(3), 298-307.
Lin, W. S., Clement, J. R., Gaucher, G. M., & Armstrong, D. A. (1975). Repairable and
nonrepariable inactivation of irradiated aqueous papain: effects of OH, O2-, eaq-, and
H2O2. Radiation Research, 62(3), 438-455.
Luo, D. Y., Smith, S. W., & Anderson, B. D. (2005). Kinetics and mechanism of the reaction
of cysteine and hydrogen peroxide in aqueous solution. Journal of Pharmaceutical
Sciences, 94(2), 304-316.
Maddumage, R., Nieuwenhuizen, N. J., Bulley, S. M., Cooney, J. M., Green, S. A., &
Atkinson, R. G. (2013). Diversity and relative levels of actinidin, kiwellin, and
thaumatin-like allergens in 15 varieties of kiwifruit (Actinidia). J Agric Food Chem,
61(3), 728-739.
Matsubara, T., Fujita, R., Sugiyama, S., & Kawashiro, K. (2006). Stability of protease in
organic solvent: Structural identification by solid-state NMR of lyophilized papain
before and after 1-propanol treatment and the corresponding enzymatic activities.
Biotechnology and Bioengineering, 93(5), 928-933.
Mazzaglia, A., Studholme, D. J., Taratufolo, M. C., Cai, R. M., Almeida, N. F., Goodman, T.,
Guttman, D. S., Vinatzer, B. A., & Balestra, G. M. (2012). Pseudomonas syringae pv.
actinidiae (PSA) Isolates from Recent Bacterial Canker of Kiwifruit Outbreaks
Belong to the Same Genetic Lineage. PLoS One, 7(5).
Meleleo, D., Gallucci, E., Notarachille, G., Sblano, C., Alessandra, S., & Micelli, S. (2012).
Studies on the Effect of Salts on the Channel Activity of Kissper, a Kiwi Fruit
Peptide. The Open Nutraceuticals Journal, 5, 136-145.
Miller, S. A., Broom, F. D., Thorp, T. G., & Barnett, A. M. (2001). Effects of leader pruning
on vine architecture, productivity and fruit quality in kiwifruit (Actinidia deliciosa cv.
Hayward). Scientia Horticulturae, 91(3–4), 189-199.




Mishra, S., & Monro, J. (2012). Kiwifruit remnants from digestion in vitro have functional
attributes of potential importance to health. Food Chem, 135(4), 2188-2194.
108
Montoya, C. A., Hindmarsh, J. P., Gonzalez, L., Boland, M. J., Moughan, P. J., & Rutherfurd,
S. M. (2014). Dietary Actinidin from Kiwifruit (Actinidia deliciosa cv. Hayward)
Increases Gastric Digestion and the Gastric Emptying Rate of Several Dietary
Proteins in Growing Rats. Journal of Nutrition, 144(4), 440-446.
Morimoto, K. T., M. Tonomura, B (2002). The steady-state and the pre-steady-state kinetic
analysis of the hydrolysis of N-α-Cbz-L-Lysine p-nitrophenyl ester catalysed by
actinidain isozymes. Memoirs of the School of B.O.S.T.(10), 29-37.
Motohashi, N., Shirataki, Y., Kawase, M., Tani, S., Sakagami, H., Satoh, K., et al. (2002).
Cancer prevention and therapy with kiwifruit in Chinese folklore medicine: a study of
kiwifruit extracts. Journal of Ethnopharmacology, 81(3), 357-364.




Nagaoka, Y., Otsu, K., Okada, F., Sato, K., Ohba, Y., Kotani, N., & Fujii, J. (2005). Specific
inactivation of cysteine protease-type cathepsin by singlet oxygen generated from
naphthalene endoperoxides. Biochemical and Biophysical Research Communications,
331(1), 215-223.
Niesen, F. H., Berglund, H., & Vedadi, M. (2007). The use of differential scanning
fluorimetry to detect ligand interactions that promote protein stability. Nature
Protocols, 2(9), 2212-2221.
Nieuwenhuizen, N. J., Beuning, L. L., Sutherland, P. W., Sharma, N. N., Cooney, J. M.,
Bieleski, L. R. F., Schröder, R., MacRae, E. A., & Atkinson, R. G. (2007).
Identification and characterisation of acidic and novel basic forms of actinidin, the
highly abundant cysteine protease from kiwifruit. Functional Plant Biology, 34(10),
946-961.
Nieuwenhuizen, N. J., Maddumage, R., Tsang, G. K., Fraser, L. G., Cooney, J. M., De Silva,
H. N., Green, S., Richardson, K. A., & Atkinson, R. G. (2012). Mapping,
complementation, and targets of the cysteine protease actinidin in kiwifruit. Plant
Physiol, 158(1), 376-388.
Notredame, C., Higgins, D. G., & Heringa, J. (2000). T-Coffee: A novel method for fast and
accurate multiple sequence alignment. J Mol Biol, 302(1), 205-217.




Offer, T., Mohsen, M., & Samuni, A. (1998). An SOD-mimicry mechanism underlies the role
of nitroxides in protecting papain from oxidative inactivation. Free Radical Biology
and Medicine, 25(7), 832-838.
Ozawa, K., Tanaka, S., & Ohnishi, T. (1962). Activation and inhibition of papain. J Biochem,
51(5), 372-374.
Petoukhov, M. V., Konarev, P. V., Kikhney, A. G., & Svergun, D. I. (2007). ATSAS 2.1 -
towards automated and web-supported small-angle scattering data analysis. Journal of
Applied Crystallography, 40, S223-S228.
Petoukhov, M. V., Svergun, D. I., Konarev, P. V., Ravasio, S., van den Heuvel, R. H. H.,
Curti, B., & Vanoni, M. A. (2003). Quaternary structure of Azospirillum brasilense
NADPH-dependent glutamate synthase in solution as revealed by synchrotron
radiation x-ray scattering. Journal of Biological Chemistry, 278(32), 29933-29939.
Podivinsky, E., Forster, R. L., & Gardner, R. C. (1989). Nucleotide sequence of actinidin, a
kiwi fruit protease. Nucleic Acids Res, 17(20), 8363.
Préstamo, G. (1995). Actinidin in kiwifruit cultivars. Zeitschrift für Lebensmittel-
Untersuchung und -Forschung, 200(1), 64-66.
Prestrelski, S. J., Tedeschi, N., Arakawa, T., & Carpenter, J. F. (1993). Dehydration-induced
conformational transitions in proteins and their inhibition by stabilizers. Biophysical
Journal, 65(2), 661-671.
Putnam, C. D., Hammel, M., Hura, G. L., & Tainer, J. A. (2007). X-ray solution scattering
(SAXS) combined with crystallography and computation: defining accurate
macromolecular structures, conformations and assemblies in solution. Quarterly
Reviews of Biophysics, 40(3), 191-285.
Rawlings, N. D., Barrett, A. J., & Bateman, A. (2012). MEROPS: the database of proteolytic
enzymes, their substrates and inhibitors. Nucleic Acids Res, 40(D1), D343-D350.
Reid, J. D., Hussain, S., Sreedharan, S. K., Bailey, T. S. F., Pinitglang, S., Thomas, E. W.,
Verma, C. S., & Brocklehurst, K. (2001). Variation in aspects of cysteine proteinase
catalytic mechanism deduced by spectroscopic observation of dithioester
intermediates, kinetic analysis and molecular dynamics simulations. Biochemical
Journal, 357, 343-352.
Riaz, M. N., Asif, M., & Ali, R. (2009). Stability of Vitamins during Extrusion. Crit Rev
110
Food Sci Nutr, 49(4), 361-368.
Ritenour, M. A., Crisosto, C. H., Garner, D. T., Cheng, G. W., & Zoffoli, J. P. (1999).
Temperature, length of cold storage and maturity influence the ripening rate of
ethylene-preconditioned kiwifruit. Postharvest Biology and Technology, 15(2), 107-
115.
Rodrigues, S., & Fernandes, F. A. N. (2012). Advances in Fruit Processing Technologies
Retrieved from http://canterbury.eblib.com.au/patron/FullRecord.aspx?p=919021
Rush, E. C., Patel, M., Plank, L. D., & Ferguson, L. R. (2002). Kiwifruit promotes laxation in
the elderly. Asia Pacific Journal of Clinical Nutrition, 11(2), 164-168.
Russo, I., Luciani, A., De Cicco, P., Troncone, E., & Ciacci, C. (2012). Butyrate Attenuates
Lipopolysaccharide-Induced Inflammation in Intestinal Cells and Crohn's Mucosa
through Modulation of Antioxidant Defense Machinery. PLoS One, 7(3).
Rutherfurd, S. M., Montoya, C. A., Zou, M. L., Moughan, P. J., Drummond, L. N., & Boland,
M. J. (2011). Effect of actinidin from kiwifruit (Actinidia deliciosa cv. Hayward) on
the digestion of food proteins determined in the growing rat. Food Chem, 129(4),
1681-1689.
Sagar, V. R., & Kumar, S. P. (2010). Recent advances in drying and dehydration of fruits and
vegetables: a review. Journal of Food Science and Technology-Mysore, 47(1), 15-26.
Sandler, R. S., Everhart, J. E., Donowitz, M., Adams, E., Cronin, K., Goodman, C., et al.
(2002). The burden of selected digestive diseases in the United States.
Gastroenterology, 122(5), 1500-1511.
Schuck, P. (2000). Size-distribution analysis of macromolecules by sedimentation velocity
ultracentrifugation and lamm equation modeling. Biophys J, 78(3), 1606-1619.
Singletary, K. (2012). Kiwifruit: Overview of Potential Health Benefits. Nutrition Today,
47(3), 133-147.
Steinmetz, K. A., & Potter, J. D. (1996). Vegetables, fruit, and cancer prevention: A review.
Journal of the American Dietetic Association, 96(10), 1027-1039.
Sugiyama, S., Ohtsuki, K., Sato, K., & Kawabata, M. (1997). Enzymatic properties, substrate
specificities and pH-activity profiles of two kiwifruit proteases. J Nutr Sci Vitaminol
(Tokyo), 43(5), 581-589.
Svergun, D. I. (1992). Determination of the regularization parameter in indirect-transform
methods using perceptual criteria. Journal of Applied Crystallography, 25, 495-503.
Tamburrini, M., Cerasuolo, I., Carratore, V., Stanziola, A. A., Zofra, S., Romano, L.,
111
Camardella, L., & Ciardiello, M. A. (2005). Kiwellin, a novel protein from kiwi fruit.
Purification, biochemical characterization and identification as an allergen. Protein
Journal, 24(7-8), 423-429.
Tello-Solis, S. R., Valle-Guadarrama, M. E., & Hernandez-Arana, A. (1995). Purification and
circular dichroism studies of multiple forms of actinidin from Actinidia chinensis
(kiwifruit). Plant Science, 106(2), 227-232.
Tommaso, P., Moretti, S., Xenarios, I., Orobitg, M., Montanyola, A., Chang, J. M., Taly, J. F.,
& Notredame, C. (2011). T-Coffee: a web server for the multiple sequence alignment
of protein and RNA sequences using structural information and homology extension.
Nucleic Acids Res, 39, W13-W17.
Tuppo, L., Giangrieco, I., Palazzo, P., Bernardi, M. L., Scala, E., Carratore, V., Tamburrini,
M., Mari, A., & Ciardiello, M. A. (2008). Kiwellin, a modular protein from green and
gold kiwi fruits: evidence of in vivo and in vitro processing and IgE binding. J Agric
Food Chem, 56(10), 3812-3817.
USDA. (2011). USDA National Nutrient Database for Standard Reference Release 24. from
http://www.ars.usda.gov/ba/bhnrc/ndl
van der Hoorn, R. A. L. (2008). Plant proteases: From phenotypes to molecular mechanisms.
Annual Review of Plant Biology, 59, 191-223.
Warrington, I. J., Weston, G. C., & Science, N. Z. S. f. H. (1990). Kiwifruit: Science and
Management: Ray Richards.
Xian, M., Chen, X. C., Liu, Z. Y., Wang, K., & Wang, P. G. (2000). Inhibition of papain by S-
nitrosothiols - Formation of mixed disulfides. Journal of Biological Chemistry,
275(27), 20467-20473.
Yoon, S. L., Grundmann, O., Koepp, L., & Farrell, L. (2011). Management of irritable bowel
syndrome (IBS) in adults: conventional and complementary/alternative approaches.
Altern Med Rev, 16(2), 134-151.
Yue, S. T., Steinberg, T. H., Patton, W. F., Cheung, C. Y., & Haugland, R. P. (2003). For
detecting and quantifying peptides, polypeptides and proteins; sensitive, facile and
does not require use of organic solvents: Google Patents.
Zespri. (2013-2014). Zespri Annual Review. Retrieved from
https://www.zespri.com/ZespriInvestorPublications/Annual-Review-2013-14.pdf
